WO1999013574A1 - Low power current-to-frequency converter circuit for use in implantable sensors - Google Patents

Low power current-to-frequency converter circuit for use in implantable sensors Download PDF

Info

Publication number
WO1999013574A1
WO1999013574A1 PCT/US1998/018978 US9818978W WO9913574A1 WO 1999013574 A1 WO1999013574 A1 WO 1999013574A1 US 9818978 W US9818978 W US 9818978W WO 9913574 A1 WO9913574 A1 WO 9913574A1
Authority
WO
WIPO (PCT)
Prior art keywords
capacitor
signal
charge
frequency
vco
Prior art date
Application number
PCT/US1998/018978
Other languages
French (fr)
Inventor
John C. Gord
Original Assignee
Alfred E. Mann Foundation For Scientific Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred E. Mann Foundation For Scientific Research filed Critical Alfred E. Mann Foundation For Scientific Research
Priority to JP2000511247A priority Critical patent/JP3958933B2/en
Priority to EP98946040A priority patent/EP1012974B1/en
Priority to AU93146/98A priority patent/AU9314698A/en
Priority to CA002303022A priority patent/CA2303022C/en
Priority to DE69819533T priority patent/DE69819533T2/en
Publication of WO1999013574A1 publication Critical patent/WO1999013574A1/en

Links

Classifications

    • HELECTRICITY
    • H03ELECTRONIC CIRCUITRY
    • H03KPULSE TECHNIQUE
    • H03K7/00Modulating pulses with a continuously-variable modulating signal
    • H03K7/06Frequency or rate modulation, i.e. PFM or PRM
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply

Definitions

  • the present invention relates to implantable medical devices, and more particularly to a very-low power current-to-frequency converter circuit that may be used within an implantable sensor to convert a small analog current, generated by the sensor as a result of having sensed a specified parameter or substance, to a variable frequency pulse train signal . A count of the pulses of the pulse train may then be made to provide an accurate digital measure of the small analog current generated from the sensor.
  • a medical device configured to perform a desired medical function, is implanted in the living tissue of a patient so that a desired function may be carried out as needed for the benefit of the patient.
  • implantable medical devices are known in the art, ranging from implantable pacemakers, cochlear stimulators, muscle stimulators, glucose sensors, and the like.
  • Some implantable medical devices are configured to perform the sensing function, i.e., to sense a particular parameter, e.g., the amount of a specified substance in the blood or tissue of the patient, and to generate an electrical signal indicative of the quantity or concentration level of the substance sensed. Such electrical signal is then coupled to a suitable controller, which may or may not be implantable, and the controller responds to the sensed information in a way to enable the medical device to perform its intended function, e.g., to display and/or record the measurement of the sensed substance.
  • a suitable controller which may or may not be implantable
  • An example of an implantable medical device that performs the sensing function is shown, e.g., in U.S. Patent No. 4,671,288.
  • the output signal generated by the sensor (which output signal represents a measure of the parameter or substance being sensed by the sensor) becomes very small (e.g., extremely small amplitude).
  • This small output signal must eventually be converted to a more useful output signal, e.g., an amplified signal, or a digital signal, before it can be used to control the medical device, or be displayed by the medical device.
  • the sensor itself is located some distance from the medical device which needs the information measured by the sensor. Hence, the sensor signal must be sent to the medical device over a suitable conductor, or otherwise transmitted to the medical device.
  • the sensor output signal is so small, it generally first be amplified, or otherwise converted to a signal in a more usable format (i.e., converted to a digital signal by an analog-to-digital (A/D) converter) before it can be reliably sent or transmitted to the medical device.
  • A/D analog-to-digital
  • Such amplification and/or A/D conversion requires additional circuitry, located at the sensor site.
  • this additional circuitry located at the sensor (which may be incorporated as part of the sensor, or becomes supplemental circuitry that must be used with the sensor) , not only places additional power demands on the system, but it also may dramatically increase the circuit complexity, size, and cost of the sensor circuitry. What is needed, therefore, is an extremely low power conversion circuit that converts the very small output signals typically obtained from implantable sensors to a signal format that facilitates the signal ' s subsequent transmission to and use by the medical device.
  • the above need is even more acute where more than one sensor must be used. More than one sensor may be needed, for example, to measure more than one substance or physiological parameter. In other instances, more than one sensor may be needed to measure or sense the same substance or physiological parameter at different locations within the patient's body.
  • More than one sensor may be needed, for example, to measure more than one substance or physiological parameter. In other instances, more than one sensor may be needed to measure or sense the same substance or physiological parameter at different locations within the patient's body.
  • the output signal (representing output data) from each sensor be first converted to a format that facilitates transmission of the sensor output signal over a shared data bus or communication channel without compromising the integrity of the data, and that such conversion not consume large, or even moderate, amounts of power.
  • the present invention addresses the above and other needs by providing a very low power current-to- frequency (I-to-F) converter circuit for use on-site with an implantable sensor that generates a low level analog current or voltage as its output signal.
  • the analog output signal generated by the sensor comprises a very small analog electrical current, e.g., having a peak magnitude on the order of only about picoamps
  • the converter circuit utilized by the implantable device comprises a low power current-to-frequency converter circuit.
  • Such low power current-to-frequency converter circuit includes: (1) an operational amplifier, (2) a first capacitor, (3) a voltage controlled oscillator (VCO), and (4) a charge pump circuit.
  • the operational amplifier preferably fabricated from low power N-MOS and P-MOS FET transistors having specific dimensions, has two input terminals and one output terminal. In operation, it differentially amplifies an electrical signal applied between its two input terminals to provide an amplified output signal appearing on its output terminal.
  • the first capacitor is connected to one of the input terminals of the operational amplifier, and is used to receive the charge provided by the input electrical current .
  • the VCO circuit has a voltage-control input terminal and a VCO output terminal, and the voltage-control input terminal is connected to the output terminal of the operational amplifier.
  • the VCO includes means for generating a VCO signal having a frequency that varies as a function of the magnitude of a control voltage applied to the voltage-control input.
  • the charge-pump circuit is coupled to the first capacitor of the operational amplifier and pumps a discrete charge off of the first capacitor under control of the frequency of the VCO signal.
  • An electrical current applied to the first capacitor e.g., from the output of the sensor, tends to cause a charge to accumulate on the first capacitor as a function of the magnitude of the electrical current, which charge tends to increase the output voltage of the operational amplifier so as to increase the frequency of the VCO signal.
  • This increased VCO frequency causes the charge to be pumped off of the first capacitor at an increased rate.
  • the operational amplifier thereby forces the frequency of the VCO signal to whatever rate is needed to maintain the charge on the first capacitor at essentially zero. In this manner, the frequency of the VCO signal varies as a function of the magnitude of the electrical current applied to the first capacitor.
  • the operational amplifier, VCO and charge pump circuit all operate using just one supply voltage having a first terminal V+, and a second terminal V- (which two terminals may sometimes be referred to as simply V and "ground") .
  • the first capacitor is connected between a first input terminal of the operational amplifier and V- , and a second input terminal of the operational amplifier is also connected to V- .
  • Using one supply voltage in this manner keeps the power consumption of the current- to-frequency converter very low.
  • the low power current-to-frequency converter circuit consumes less than about 600 nanoamps (na) of current .
  • the I-to-F converter circuit may be included within the hermetically-sealed part of an implantable sensor that includes both a non-hermetically sealed part (containing, e.g., electrodes, connection terminals, and/or sensor materials that must be in contact with body fluids or tissue) and an hermetically sealed part (containing electrical circuitry to manage, monitor and/or control the non-hermetically sealed part) .
  • a first pair of terminals is included as part of the non- hermetically sealed part and functions as the input/output terminals for connecting the implantable sensor to an implantable medical device over a connection bus that includes just two conductors, one conductor being connected to each terminal.
  • Both operating power and control data are transmitted over the two-conductor bus from the medical device to the sensor; and sensed data, converted to a suitable form for transmission by the I-to-F converter of the present invention, is transmitted over the same two-conductor bus from the implantable sensor to the medical device.
  • the first pair terminals (or a second pair of terminals electrically connected to the first pair of terminals) , may also function as connection terminals for attaching additional implantable sensors to the connection bus, in daisy-chain fashion, as disclosed in applicant's copending patent, entitled DAISY-CHAINABLE SENSORS AND STIMULATORS FOR
  • an implantable sensor e.g., an implantable glucose sensor
  • It is another feature of the invention to provide a very low power, implantable I-to-F converter circuit that accumulates input current (I) on a storage capacitor, generates a control voltage as a function of the charge on the storage capacitor, drives a VCO with the control voltage so as to produce a VCO output signal having a frequency (F) that varies as a function of the control voltage, and pumps a discrete charge off of the first capacitor under control of the frequency of the VCO signal so as to maintain the charge on the first capacitor at approximately zero, thereby converting input current (I) to an output frequency (F) .
  • FIG. 1 is a block diagram that illustrates multiple sensors/stimulators connected together using a two-conductor bus, which two-conductor bus may be connected to a controller;
  • FIG. 2 schematically illustrates a preferred manner of how a sensor made in accordance with the present invention may be connected with a controller and other sensors in a serial or daisy-chain fashion;
  • FIG. 3A shows a perspective, partially exploded, view of a sensor of the type used in the daisy chain of FIG. 2;
  • FIG. 3B illustrates a sectional side view of the sensor of FIG. 3A
  • FIG. 3C illustrates a sectional top view of the sensor of FIG. 3A
  • FIG. 3D illustrates a sectional end view of the sensor of FIG. 3A
  • FIG. 4 depicts an implantable lead that includes a plurality of the sensors of FIGS. 3A-3D;
  • FIG. 5A is a functional block diagram of a simple daisy-chainable implantable sensor that includes an I-to-F converter circuit in accordance with the present invention
  • FIG. 5B is a functional block diagram as in FIG. 5A, but wherein an alternate connection scheme is used for attaching additional sensors;
  • FIG. 5C is a functional block diagram as in FIG. 5A, but wherein additional circuit functions are provided so that a wide variety of different sensors and a stimulator may be included within the same implantable sensor device, and wherein multiple I-to-F converter circuits are included as part of the device;
  • FIG. 6 is a timing diagram that illustrates input and output data sent to and received from an implantable sensor of the type shown in FIG. 5A, 5B or 5C;
  • FIG. 7 illustrates a data frame used to communicate with the implantable sensor of the present invention
  • FIG. 8 is a timing diagram that illustrates time multiplexed input and output data within a data frame as it appears on the two-conductor bus connecting a plurality of daisy-chainable devices of the type shown in FIG. 5A, 5B or 5C;
  • FIG. 9 shows a functional block diagram of a I-to-F converter circuit made in accordance with the present invention.
  • FIG. 10A shows a schematic diagram of the OP AMP portion of the I-to-F converter circuit shown in FIG. 9
  • FIG. 10B shows a schematic diagram of the VOLTAGE BUFFER and CHARGE PUMP portions of the I-to-F converter circuit shown in FIG. 9;
  • FIG. IOC shows a schematic/logic diagram of the VCO portion of the I-to-F converter circuit shown in FIG. 9;
  • FIG. 10D shows a timing waveform diagram associated with the operation of the VCO circuit of FIG. IOC.
  • FIGS. 3 and 10 refer respectively to all of the figures associated with that number, i.e., a generic reference to “FIG. 3” refers to all of FIGS. 3A, 3B, 3C and 3D; a generic reference to “FIG. 5" refers to all of FIGS. 5A, 5B and 5C; and a generic reference to “FIG. 10” refers to FIGS. 10A, 10B, IOC and 10D.
  • the present invention relates to a very low power current-to-frequency (I-to-F) converter circuit, described more fully below in connection with FIGS. 9-10.
  • I-to-F converter circuit converts an analog input signal, i.e., a very low amplitude electrical current, to a variable frequency output signal.
  • Such output signal has a frequency that varies as a function of the magnitude of the analog input current .
  • the I-to-F converter circuit provided by the present invention is especially well suited for use within an implantable sensor of the type described in connection with FIGS. 1-8. It is to be understood, however, that the invention is not limited to use only within sensors of the type described in connection with in FIGS. 1-8; rather the sensors and sensor systems of the type described in connection with FIGS. 1-8 merely represent the best mode currently contemplated for using an I-to-F converter circuit within an implantable sensor.
  • FIGS. 1-8 A more thorough description of each of FIGS. 1-8 may be found in applicant's copending patent application entitled: DAISY- CHAINABLE SENSORS AND STIMULATORS FOR IMPLANTATION IN LIVING TISSUE, Serial No. , filed
  • FIG. 1 there is shown a block diagram that illustrates multiple sensors 12a, 12b,
  • ... 12n or other implantable devices, connected together, as well as a controller (not shown in FIG. 1) using just two common conductors 14 and 16.
  • the two conductors 14 and 16 commonly referred to as a two- conductor connection "bus"
  • FIG. 2 schematically illustrates how an implantable sensor/stimulator 18a be connected with a remote controller 20 and other implantable devices 18b, ... 18n, in a serial or daisy-chain fashion. As seen in
  • the device 18a is connected to the controller 20 by two conductors 14' and 16' of the connection bus, which are attached to a first pair of pads or terminals 13 and 15 along a proximal side (i.e, the side closest to the controller 20) of the device 18a.
  • Another pair of pads or terminals 17 and 19 are located along a distal side (i.e., the side farthest from the controller 20) of the device 18a.
  • the distal pad 17 is electrically connected to the proximal pad 13 through the circuitry 21 located on the device 18a.
  • the distal pad 19 is electrically connected to the proximal pad 15 through the circuitry 21 included within the device 18a.
  • Two additional conductors 14" and 16" are then used to connect the distal pads 17 and 19 of the device 18a to corresponding proximal pads 13' and 15' of the next device 18b connected in the daisy chain. In this manner, as many devices as desired may be serially connected to the controlled 20 using just two conductors.
  • the sensor 12 or 18 is designed to sense one or more body parameters or substances found in body tissue or fluids, e.g., glucose level, blood pH, 0 2 , temperature, or the like. Such measurements can provide valuable information regarding the condition and status of the patient.
  • FIGS. 3A, 3B, 3C and 3D there are shown, respectively, a perspective exploded view (FIG. 3A) , a side view (FIG. 3B) , a top view (FIG. 3C) , and an end view (FIG. 3D) , of a typical implantable sensor device 30 of a type suited for use with the present invention.
  • the sensor device 30 typically includes a carrier or substrate 36 on which an integrated circuit (IC) 38 and other components, such as a capacitor 40, are mounted.
  • IC integrated circuit
  • the carrier or substrate 36 may actually comprise the substrate on which the IC 38 is fabricated; but for purposes of the explanation which follows, it is assumed that a separate substrate or carrier 36 is employed with various circuit elements mounted thereon to form a hybrid circuit.
  • the carrier or substrate has conductive patterns etched or otherwise deposited thereon to interconnect the IC 30, capacitor 40, and any other components to form a hybrid circuit which carries out the desired sensing (or other) function.
  • All of the components of the hybrid circuit are hermetically sealed within a cavity formed by a lid or cover 42 which is bonded to the substrate 36.
  • Proximal pads or terminals 13 and 15, as well as distal pads or terminals 17 and 19, remain outside of the hermetically sealed part of the hybrid circuit. These proximal and distal pads, however, are electrically connected to the circuitry within the hermetically sealed part through suitable feedthrough connections .
  • feedthrough connection One manner of making such feedthrough connection is to use a feedthru connection that passes through the carrier or substrate in the stair-step manner (including both vertical and horizontal segments) disclosed in co-pending patent application, Serial Number 08/515,559, filed 08/16/95, entitled “Hermetically-Sealed Electrical Feedthrough For Use With Implantable Electronic Devices", which application is assigned to the same assignee as is the instant application, and which application is incorporated herein by reference.
  • a suitable electrochemical sensor 44 On the side of the carrier or substrate opposite the hybrid electrical circuitry, a suitable electrochemical sensor 44, or other desired type of sensor or stimulator, may be formed or located.
  • the precise nature of the sensor 44, or other implantable element used within the device 30, is not critical. All that matters is that the sensor or other element be implantable, and that it provide a desired function, e.g., sense a certain type of parameter of substance, or generate a certain type of signal, in response to an appropriate control signal or signals.
  • Signal communication between the hybrid circuit side of the substrate or carrier 36 (which is the top side as the device 30 is oriented in FIG. 3B or FIG. 3D, and which top side includes the hermetically sealed portion of the device) and the sensor side of the device 30 (which is the bottom side as shown in FIG. 3B or 3D) is achieved by way of appropriate hermetically-sealed feedthroughs that pass step-wise from the hybrid (top) side of the device 30 through the substrate or carrier, e.g., in the manner set forth in the above-referenced '559 patent application.
  • FIG. 2 The configuration illustrated in FIG. 2 is especially well-suited where several of the implantable devices are to be daisy-chained together to form a single lead 32, as shown in FIG. 4.
  • three sensor-type devices 30a, 30b, and 30c are connected together via lead segments 46a, 46b, and 46c.
  • Each of the lead segments 46a, 46b, and 46c contain two conductors 14, 16, and may be constructed in any suitable manner, e.g., with the two conductors being spirally wound within the lead segments, and with the spiral windings being encased or covered within a sheath of silicone rubber, as is known in the lead art.
  • a distal cap 34 covers the distal pads of the end, or most-distal, device 30c of the lead 32.
  • the low power current-to- frequency converter circuit of the present invention may be included as part of the electrical circuitry contained within or included as a part of what is referred to above as the "hybrid circuit portion" of the implantable device 30.
  • such electrical circuitry allows the implantable device 30 to be daisy chained with other similar implantable devices, while still allowing each individual device to be individually addressed, controlled and monitored from a single controller 20.
  • the I-to-F converter circuit of the present invention converts low level analog signals obtained from the sensor 44, or elsewhere, to be converted to a frequency, which frequency can then be easily counted over a fixed time period to create a digital signal representative of the sensor's analog output. Such digital signal can thereafter be more reliably transmitted over the two- conductor bus to the controller 20.
  • FIGS. 5A, 5B and 5C show three such variations.
  • FIG. 5A for example, is a functional block diagram of a basic configuration of control/interface circuitry 50 for use with a sensor 52.
  • the dotted line 54 represents an hermetic seal that hermetically seals the circuitry 50 and all but a portion of the sensor 52.
  • the input pads 13 and 15, as well as the output pads 17 and 19, are not hermetically sealed, thereby allowing these pads to be readily connected to the two conductors 14 and 16 (FIG. 1) from the controller 20.
  • pads 13 and 15 are connected to respective conductive traces, labeled LINE 1 (IN) and LINE 2 (IN) , representing the two conductors of the two-conductor bus that connects the device 30 to its controller 20, or to other devices.
  • Each of the LINE 1 and LINE 2 conductive traces passes through respective feedthroughs 53 and 55 into the hermetically sealed portion of the circuitry 50.
  • Pads 17 and 19, on the other side of the circuit are likewise connected to respective conductive traces, labeled LINE 1 (OUT) and LINE 2 (OUT) , and each of these conductive traces passes through respective feedthroughs 57 and 59 into the hermetically sealed portion 54 of the circuitry 50.
  • LINE 1 connects with LINE 1 (OUT) via conductive trace 56
  • LINE 2 connects with LINE 2 (OUT) via conductive trace 58.
  • pad 13 is electrically connected with pad 17 via trace 56 which passes through the hermetically sealed portion 54 between feedthroughs 53 and 57.
  • This interconnection of pad 13, trace 56 and pad 57 is referred to hereafter simply as LINE 1.
  • pad 15 is electrically connected with pad 19 via trace 58, which trace also passes through the hermetically sealed portion 54 between feedthroughs 55 and 59. This interconnection is referred to hereafter as LINE 2.
  • a power rectifier circuit 60 is connected between LINE 1 and LINE 2. This circuit extracts and rectifies any signal pulses found on LINE 1 and LINE 2 and produces an operating voltage, +V and -V, for powering the circuitry 50. Such rectification is not a trivial task given the low level signals which are generally present on LINE 1 and LINE 2, which signals are usually well below the 0.6-0.8 voltage drop of a conventional silicon diode. Details of such circuitry may be found in copending patent application A LOW POWER
  • a line interface circuit 62 also is connected between LINE 1 and LINE 2.
  • the circuit 62 functions as an interface between the circuitry 50 and LINE 1 and LINE 2.
  • the interface circuit 50 receives incoming data pulses present on LINE l/LINE 2 and generates a DATA-IN signal on line 64 therefrom.
  • the interface circuit 62 further generates a clock (CLK) signal on line 66 that is synchronized with the incoming data signals.
  • CLK clock
  • the interface circuit 50 also receives digital output data, DATA OUT, from a counter circuit 68, and converts this output data to an appropriate format prior to placing the output data back on LINE l/LINE 2.
  • One type of line interface circuit 62 that may be used with the circuitry 50 is illustrated in the schematic diagram shown and explained below in conjunction with FIG. 9.
  • the senor 52 may be any suitable sensor adapted to sense a desired condition, parameter, or substance present (or absent) in the implantable tissue within which the device 30 is implanted.
  • the sensor 52 may comprise a glucose sensor that generates an output analog current, I, appearing on line 69, having a magnitude that varies as a function of the sensed glucose.
  • the type of sensor 52 it will usually generate either an analog output voltage or an analog output current as a function of the concentration, magnitude, composition, or other attribute, of the parameter being sensed. Such analog current or voltage may then be converted, using an appropriate converter circuit 70, to a frequency signal, appearing on line 72.
  • the frequency signal on line 72 comprises a train of pulses having a frequency (or repetition rate) that varies as a function of the input voltage or current.
  • the sensor 52 generates an output current I
  • the converter circuit 70 comprises a current-to- frequency (I-to-F) converter circuit, generating an output pulse train on line 72 that has a frequency which varies as the magnitude of the current J varies. It is this I-to-F converter circuit
  • a pulse train 72 or other ac signal, is generated having a frequency which varies as a function of the parameter being sensed by the sensor 52, such signal is applied to a counter circuit 68.
  • a signal appearing on signal line having a given reference number may be referred to as the signal having such given reference number, i.e., the signal appearing on signal line 72 may simply be referred to as "signal 72".
  • the counter circuit simply counts the number of pulses present in the signal 72 over a prescribed period of time, e.g., a fixed time window of 1 second, thereby providing a measure of the frequency of the signal 72.
  • the count held in the counter at the end of the measurement period provides a signal representative of the frequency of the signal 72.
  • Such count signal may thus serve as the output data signal, DATA OUT, that is sent to the line interface circuit 62 over signal line 74.
  • Control of the counter 68 i.e., resetting the counter and/or stopping the counter after a prescribed measurement period, is controlled by control logic 76.
  • the measurement period may be a fixed time period. In other embodiments, the measurement period may be set by input data received over signal line 64 from the line interface circuit 62.
  • the clock signal 66 may be used as a measure of elapsed time, as well as to coordinate when the counter 68 sends its DATA OUT signal 74 to the line interface circuit 62.
  • a voltage generator circuit 78 generates a reference voltage V REP , and one or more bias signal (s) , V BIAS , that are used by the current-to- frequency (I-to-F) converter circuit 70 as it performs its function of converting the analog current signal 69 to a frequency signal 72, as explained more fully below in connection with FIGS. 9 and 10.
  • one or more I-to-F converter circuits may be used within the devices illustrated in FIGS. 5B and 5C, as described in the above-referenced copending patent application, entitled: DAISY-CHAINABLE SENSORS AND STIMULATORS FOR IMPLANTATION IN LIVING TISSUE.
  • FIG. 2 where a plurality of implantable, daisy-chainable sensors 18a, 18b ...18n are shown connected in tandem, a preferred manner of operation is for the controller 20 to provide operating power to, as well as to individually address and send data to and receive data from, each of the devices 18 that are connected thereto over the two- conductor bus made up of the conductors 14 and 16.
  • One manner in which such powering and individual addressing is done is as shown in connection with FIGS. 6, 7 and 8.
  • FIG. 6 One manner in which such powering and individual addressing is done is as shown in connection with FIGS. 6, 7 and 8.
  • each biphasic pulses comprises a first current pulse of a first polarity, followed by a second current pulse of the same magnitude of the opposite polarity.
  • the net current for each biphasic pulse is preferably zero, with the positive current pulse effectively balancing out the negative current pulse.
  • the typical widths of the current pulses are from to msec, with the magnitude of each current pulse typically ranging from to microamps .
  • a binary or logical "1" is represented by a biphasic pulse of one phase, e.g., a positive current pulse followed by a negative current pulse; while a binary or logical "0” is represented by a biphasic pulse of the opposite phase, e.g., a negative pulse followed by a positive pulse.
  • a binary "1” may be represented as a positive current pulse followed by a negative current pulse, while a binary "0” is represented by a negative current pulse followed by a positive current pulse .
  • the preferred form for the output data is also a biphasic pulse, amplitude modulated (or preferably ON/OFF modulated) as a function of whether the output data is a binary "1" or "0".
  • the peak amplitude of the output data pulse for a binary "1” is I p/ while the peak amplitude of the output data pulse for a binary "0" is zero.
  • the presence of an output data pulse represents a binary "1" and the absence of an output data pulse represents a binary "0".
  • Output data pulses are inserted in the data stream appearing on the LINE l/LINE 2 conductors pulses at a specified time T2 from the input data pulse so as to fall between the input data pulses, in a time-division multiplexed manner.
  • the preferred form of the output data pulses is a biphasic pulse (to achieve current balancing)
  • a monophasic pulse at time T2 and with amplitude of I p or zero
  • the input data sent over the LINE l/LINE 2 conductors by the controller is divided into data frames of length T3. Within each data frame, N bits of data are found, where N is an integer typically ranging from 8 to 64. A representative assignment of the data bits included in the data frame is illustrated in FIG. 7.
  • the input data comprises biphasic pulses that occur at a regular interval or rate (e.g., every Tl seconds)
  • the energy contained in such pulses may be utilized to provide the operating power for the circuits contained within the device 50". Such is accomplished using the rectifier circuit 60, 60' or 60" (FIGS. 5A, 5B or 5C) .
  • the input and output data pulses of the type shown in FIGS. 6 and 8 are generated by the line interface circuit 62, 62' or 62" (FIGS. 5A, 5B or 5C) .
  • a schematic diagram of a preferred line interface circuit is described in the above-referenced copending patent application, Attorney Docket No. 56287 (see particularly FIG. 9 of the referenced application, and its accompanying text) .
  • the current-to-frequency converter 150 includes four main functional elements. These four main functional elements include: (1) an operational amplifier 152 having a positive input terminal 153a and a negative input terminal 153b, and an output terminal 154; (2) a capacitor C4 connected to the positive input terminal 153a of the operational amplifier 152; (3) a voltage controlled oscillator (VCO) circuit 156 having a voltage-control input terminal and a VCO output terminal, the VCO input terminal being connected to the output terminal 154 of the operational amplifier 154, and the VCO output terminal providing a variable frequency output signal F ou ⁇ ; and (4) a charge-pump circuit 158 coupled to capacitor C4 (i.e., also connected to positive input terminal 153a of the operational amplifier 152.
  • VCO voltage controlled oscillator
  • the analog input signal, J IN charges up the capacitor C4.
  • the amount of charge accumulated by capacitor C4 is a function of the magnitude of the input current I 1N , which input current reflects a measure of the parameter or other condition being sensed by the sensor or otherwise monitored from within the implantable device 30.
  • the charge pump circuit 158 pumps a discrete charge (i.e., a fixed number of coulombs) off of capacitor C4 during each cycle of the F om signal generated by the VCO 156.
  • the operational amplifier 152 differentially amplifies an electrical signal applied between its two input terminals 153a and 153b to produce an amplified output signal on its output terminal 154.
  • the differential input signal applied to the operational amplifier 152 is effectively the amount of charge, or voltage, that has accumulated on the capacitor C4.
  • the amplified output signal from the operational amplifier 152 comprises a voltage that varies as a function of the input current I IN .
  • This amplified output signal is applied to the VCO 156 as a control voltage, causing the frequency output signal, F ou ⁇ , of the
  • VCO to have a frequency that varies as a function of the input current, J IN .
  • the output frequency signal from the VCO, F ou ⁇ besides being available as an variable frequency output signal F ou ⁇ that can be counted over a fixed period of time (as described above in connection with FIG. 5A) , is also applied to the charge pump circuit 158.
  • This output frequency signal F ou ⁇ typically comprises a pulse train, the frequency of which varies as a function of the magnitude of a voltage applied to the voltage-control input.
  • the charge pump circuit 158 pumps a discrete charge off of the capacitor C4.
  • the input current J IN causes a charge to accumulate on capacitor C4 , which charge tends to increase the output voltage of the operational amplifier 152 so as to increase the frequency of the F ou ⁇ output signal.
  • a voltage buffer circuit 160 may be employed as part of the I-to-F conversion circuit 150 of FIG. 9 to produce a stable and isolated reference voltage V REP , which reference voltage is used by the charge pump circuit 158 as it performs its charge pumping function.
  • the advantageous feature of the I-to-F circuit 150 of FIG. 9 is that it can be configured, using low power FET transistors, to operate so as to consume very little power. Such a low power configuration is shown and described below in connection with FIGS. 10A, 10B, 10C and 10D.
  • the I-to-F converter circuit 150 is preferably realized using a miniature integrated circuit (IC) , configured, e.g., with specific combinations of N-channel and P-channel field effect transistors (FETs) , denoted as "N-FET” and "P-FET” transistors, formed on a common substrate, and specifically designed for low power consumption.
  • IC integrated circuit
  • FETs field effect transistors
  • the preferred sizes (length and width) of each of the relevant N-FET or P-FET transistors are listed in Table 1, along with other component values of interest.
  • the N-FET and P-FET dimensions shown in Table 1 relate to the relative size of each transistor as it is formed on the IC substrate. More particularly, an N-FET, for example, having a size of "5/10" means that [***John: please add a sentence or two that describes what these values mean.**]
  • This type of characterization (by dimension or size) of the various N-FET and P-FET transistors used within an IC is known and understood by those of skill in the semiconductor processing art.
  • the performance of the FET transistors can be controlled or tailored for the specific design for which the transistor is used.
  • a relatively “long" N-FET having a size of, e.g., 5/10, may exhibit a higher turn-on resistance (and hence a slower turn on time) than would, e.g., a relatively “short” N-FET, having a size of 4/4.
  • a FET transistor has three terminals, a "source”, a “drain” and a “gate”.
  • the voltage applied to the gate terminal controls the conductivity of the semiconductor channel that connects the source and drain terminals.
  • the amount of current that flows through the channel can be controlled, from zero current to a maximum current (determined by the ON resistance and the available voltage drop across the channel) .
  • a common use for a FET transistor is as a switch. When used as a switch, the conductivity of the source-drain channel, as controlled by the voltage applied to the base terminal, is either very low (the FET switch is ON) or very high (the FET switch is OFF) .
  • an N-FET is depicted in classical FET form, i.e., appearing generally as a forward or backwards block letter "C", made up of three segments, with one end of one segment of the "C” comprising the "source”, and with one end of another segment of the "C” (which end is marked with a heavy dot nearby) comprising the "drain” .
  • the "gate” is depicted as a short line that is parallel to, but not touching, the middle segment of the "C” .
  • a P-FET is depicted the same as an N-FET except that a diagonal line is drawn through the "C” .
  • a preferred operational amplifier (OP AMP) 152 is shown schematically in FIG. 10A.
  • P-FET M10 is biased by a external voltage reference signal BIASP so as to form a constant current source of a few nanoamps to a differential pair of transistors Mil and M12. So long as the base voltage applied to each of the differential pair Mil and M12 is equal, the current from the current source M10 is equally split between Mil and M12.
  • N-FETs M13 and M14 are permanently biased ON to provide a current mirror, which in effect functions as a fixed load resistance for the differential pair Mil and M12.
  • the base terminal of Mil is connected to one side of a storage capacitor C4.
  • the other side of the capacitor C4 is grounded (connected to V-) .
  • the base terminal of M12 is connected to ground (V-) .
  • the input terminal of the OP AMP 152 comprises the gate of Mil.
  • any input current, I IN that flows into the OP AMP, begins to charge up C4 , causing a voltage to appear at the gate of Mil that is different than the voltage applied to the gate of M12.
  • transistor Mil is a P-FET transistor, a higher gate voltage (as would occur when an input current I IN starts to charge capacitor C4) tends to turn Mil OFF (increases its resistance) .
  • This increase in resistance causes the constant current from the current source M10 to be unevenly split between the two M11/M12 paths.
  • an increase in the input voltage applied to the gate of Mil causes an increased current to flow through the M12 leg of the OP AMP, thereby causing the output voltage, V ou ⁇ (which is the voltage at the drain of M12) , on signal line 154, as measured relative to ground (V- ) , to increase.
  • V ou ⁇ which is the voltage at the drain of M12
  • V- ground
  • the output voltage V ou ⁇ of the OP AMP 152 may swing from near ground (V-) to about 1.5 volts.
  • a capacitor C3 is connected between the output terminal of the OP AMP (drain of M12) and filters this output voltage to a desired extent.
  • a schematic/logic diagram of a preferred low power VCO is illustrated in FIG. IOC, and a timing waveform diagram that illustrates the basic operation of the VCO 156 is shown in FIG. 10D.
  • gates 162 through 174 included in the low power VCO of FIG. IOC (which are configured as a cross- coupled latch with active-high inputs) are shown in logic diagram form. It is to be understood, however, that such gates are preferably configured using additional N-FET and P-FET transistors, as is known in the art.
  • VCO The operation of the VCO is best understood by considering what happens just after the output of gate 172 (identified in FIG. IOC and 10D as CLK B ) goes high. This turns off M15 and allows the drain of M15 (which is the same point as the drain of Ml6) to ramp toward ground (V-), as seen in FIG. 10D. The slope of the ramp depends on the capacitance on the drain node and on the drain current (and hence gate voltage) of M16. When the drain voltage of M15/M16 ramps down to about one threshold below V+, P-FET M21 turns ON, causing an input of gate 164 to go positive over signal line 176 (FIG. IOC) .
  • the output of gate 164 goes low, turning on M24 (via signal line 178) .
  • This action provides hysteresis by reinforcing the high-going signal at the input of gate 164 (via signal line 176) .
  • the output of gate 164 reaches the logic threshold of gate 170, and the latch (i.e., the cross-coupled latch with active-high inputs made up of gates 162-172) flips state.
  • N-FETs M17 and M20 function as current sources that limit the capacitance charging current in the VCO to about 50 na . Such limiting prevents a lockup conduction which would otherwise occur if the VCO attempted to operate above its normal maximum frequency.
  • the nominal frequency of the VCO 156 is about KHz, with a typical minimum operating frequency of KHz, and a typical maximum operating frequency of KHz.
  • the frequency versus voltage relationship of the VCO shown in FIG. IOC is not linear (since it depends on the drain current versus gate voltages of N-FETs M16 and M19) .
  • the overall current-to-frequency linearity depends only on the repeatability of the charge pump, and that is designed, as explained below, to pump a fixed charge of about 6 picocoulombs (pC) with every flip of the VCO.
  • VCO 156 shown in FIG. IOC One special feature associated with the VCO 156 shown in FIG. IOC is that the NOR gates 162 and 164 each include a series bias FET that limits the supply current to less than 100 na when the logic inputs are at voltages between the supply rails, i.e., between V+ and V- .
  • the charge pump circuit 158 includes eight N-FET transistors, Ml through M8. In operation, the charge pump circuit emits fixed size packets of charge to the circuit input node, over signal line 180. The amount of charge is determined by the value of capacitors Cl and C2 and by a reference voltage V REF .
  • the reference voltage V REF comprises a buffered reference voltage that is generated by the voltage buffer circuit 160, shown in the upper half of FIG. 10B.
  • Other reference voltages used by the I-to-F converter circuit 150 include an unbuffered reference voltage V R , a BIASP reference voltage, and a BIASN reference voltage.
  • the BIASP reference voltage includes a current limiter (i.e., a pullup resistor) in series therewith that limits the current from the BIASP reference to less than about 100 na.
  • the operation of the charge pump circuit 158 is as follows: during one state of the VCO, i.e., when CLK A is low and CLK B is high, M3 and M4 are ON, and Ml and M2 are OFF. In this condition, capacitor Cl charges to the reference voltage, V REF .
  • V REF the reference voltage
  • the VCO state flips, i.e., when CLK A goes high and CLK B goes low, M3 and M4 turn OFF, and then Ml and M2 turn ON. This then causes Cl to discharge via signal line 180 (which is connected to the input of the OP AMP 152) , causing the otherwise high- going input signal line (recall that input current I IN is charging capacitor C4) to be pulled back towards ground (V-) .
  • the second capacitor C2 works in tandem with the first capacitor Cl . That is, while capacitor Cl is charging up to V REF , capacitor C2 is discharging via signal line 180 back to ground (V-) . While capacitor C2 is charging up to V REF , capacitor Cl is discharging via signal line 180 back to ground. Each time that Cl or C2 discharges, it pulls charge off of the input capacitor C4 via signal line 180. The net result is that the I-to-F converter maintains the input terminal 153a of the OP AMP 152 at the same potential as the input 153b, which is V- (ground) . Thus, it is seen that with each flip of the VCO, a charge packet is pumped off of the input capacitor C4. Since these charge packets are the only current flowing from the sensor, and since they are all the same size, their frequency is directly related to the input current I IN .
  • the sizes of the various FETs used within the charge pump circuit 158, and the VCO 156, are chosen so that the capacitors Cl and C2 are fully charged and discharged during each phase of the VCO operation, even at the highest frequencies of normal operation.
  • the timing of the two VCO outputs, CLK A and CLK B ensures a break-before-make action on the switches connected to the charge pump capacitors Cl and C2.
  • the voltage buffer circuit 160 is employed.
  • Such buffer circuit comprises, as seen in the upper half of FIG. 10B, a conventional OP AMP follower circuit composed of FET transistors M29-M35.
  • the overall power consumption of the I-to-F converter circuit described in connection with FIG. 10 is only about 1.8 picowatts (assuming a 3 volt operating voltage, and 600 na operating current) .
  • the quiescent operating current of the device is less than about 100 na.
  • Such low power operation is one of the salient features of the I-to-F converter circuit of the present invention.
  • Another important feature of the invention is that the input terminal of the I-to-F converter circuit 150, which is terminal 153a of the OP AMP 152, is maintained at essentially ground potential without the necessity of a second voltage supply.
  • the present invention provides a low power current-to- frequency converter circuit usable, e.g., in an implantable sensor device wherein there is a need to convert a low level analog signal, such as a very small electrical dc current, the magnitude of which is representative of a sensed parameter or substance, to a digital value that can be better transmitted over a shared communication bus to a remote receiver.
  • a low level analog signal such as a very small electrical dc current, the magnitude of which is representative of a sensed parameter or substance

Abstract

A low power current-to-frequency converter circuit provides an output frequency signal FOUT having a frequency that varies as a function of a low level analog input current signal. The analog input current signal is typically generated by an implantable sensor element, designed to sense a particular substance or parameter within body tissue or fluids to which the sensor is exposed, with the magnitude of the analog signal providing a measure of the sensed substance or parameter. Conversion of the low level analog current to the output frequency signal facilitates transmission of the data signal over a shared data bus and other digital processing of the data signal. The current-to-frequency converter circuit is fabricated from low power FET-based integrated circuits, and includes an operational amplifier having its positive input terminal connected to a storage capacitor that is charged by the analog input current signal, a voltage-controlled oscillator driven by the charge (voltage) on the storage capacitor that produces the output frequency signal, and a charge pump circuit that pumps a discrete amount of charge off of the storage capacitor during each cycle of the output frequency signal.

Description

LOW POWER CURRENT-TO-FREQUENCY CONVERTER CIRCUIT FOR USE IN IMPLANTABLE SENSORS
Field of the Invention
The present invention relates to implantable medical devices, and more particularly to a very-low power current-to-frequency converter circuit that may be used within an implantable sensor to convert a small analog current, generated by the sensor as a result of having sensed a specified parameter or substance, to a variable frequency pulse train signal . A count of the pulses of the pulse train may then be made to provide an accurate digital measure of the small analog current generated from the sensor.
Background of the Invention
In the implantable medical device field, a medical device, configured to perform a desired medical function, is implanted in the living tissue of a patient so that a desired function may be carried out as needed for the benefit of the patient. Numerous examples of implantable medical devices are known in the art, ranging from implantable pacemakers, cochlear stimulators, muscle stimulators, glucose sensors, and the like.
Some implantable medical devices are configured to perform the sensing function, i.e., to sense a particular parameter, e.g., the amount of a specified substance in the blood or tissue of the patient, and to generate an electrical signal indicative of the quantity or concentration level of the substance sensed. Such electrical signal is then coupled to a suitable controller, which may or may not be implantable, and the controller responds to the sensed information in a way to enable the medical device to perform its intended function, e.g., to display and/or record the measurement of the sensed substance. An example of an implantable medical device that performs the sensing function is shown, e.g., in U.S. Patent No. 4,671,288.
As medical devices have become more useful and numerous in recent years, there is a continual need to provide very low power sensors that may be connected to, or incorporated within, such devices so that the desired function of the device can be carried out without the expenditure of large amounts of power (which power, for an implanted device, is usually limited.)
Moreover, as the power consumption of many implantable sensors is deliberately designed to be very low, the output signal generated by the sensor (which output signal represents a measure of the parameter or substance being sensed by the sensor) becomes very small (e.g., extremely small amplitude). This small output signal must eventually be converted to a more useful output signal, e.g., an amplified signal, or a digital signal, before it can be used to control the medical device, or be displayed by the medical device. Further, ofttimes the sensor itself is located some distance from the medical device which needs the information measured by the sensor. Hence, the sensor signal must be sent to the medical device over a suitable conductor, or otherwise transmitted to the medical device. Because the sensor output signal is so small, it generally first be amplified, or otherwise converted to a signal in a more usable format (i.e., converted to a digital signal by an analog-to-digital (A/D) converter) before it can be reliably sent or transmitted to the medical device. Unfortunately, such amplification and/or A/D conversion requires additional circuitry, located at the sensor site. Disadvantageously, this additional circuitry located at the sensor (which may be incorporated as part of the sensor, or becomes supplemental circuitry that must be used with the sensor) , not only places additional power demands on the system, but it also may dramatically increase the circuit complexity, size, and cost of the sensor circuitry. What is needed, therefore, is an extremely low power conversion circuit that converts the very small output signals typically obtained from implantable sensors to a signal format that facilitates the signal ' s subsequent transmission to and use by the medical device.
The above need is even more acute where more than one sensor must be used. More than one sensor may be needed, for example, to measure more than one substance or physiological parameter. In other instances, more than one sensor may be needed to measure or sense the same substance or physiological parameter at different locations within the patient's body. Whenever multiple sensors are implanted and are intended to be used in concert to achieve a desired medical function, there is a corresponding need to connect or couple such separate multiple sensors to a single control circuit or common control point. Hence, there is a critical need that the output signal (representing output data) from each sensor be first converted to a format that facilitates transmission of the sensor output signal over a shared data bus or communication channel without compromising the integrity of the data, and that such conversion not consume large, or even moderate, amounts of power.
Summary of the Invention
The present invention addresses the above and other needs by providing a very low power current-to- frequency (I-to-F) converter circuit for use on-site with an implantable sensor that generates a low level analog current or voltage as its output signal. In accordance one aspect of the invention, the analog output signal generated by the sensor comprises a very small analog electrical current, e.g., having a peak magnitude on the order of only about picoamps, and the converter circuit utilized by the implantable device comprises a low power current-to-frequency converter circuit. Such low power current-to-frequency converter circuit includes: (1) an operational amplifier, (2) a first capacitor, (3) a voltage controlled oscillator (VCO), and (4) a charge pump circuit.
The operational amplifier, preferably fabricated from low power N-MOS and P-MOS FET transistors having specific dimensions, has two input terminals and one output terminal. In operation, it differentially amplifies an electrical signal applied between its two input terminals to provide an amplified output signal appearing on its output terminal. The first capacitor is connected to one of the input terminals of the operational amplifier, and is used to receive the charge provided by the input electrical current . The VCO circuit has a voltage-control input terminal and a VCO output terminal, and the voltage-control input terminal is connected to the output terminal of the operational amplifier. The VCO, as is known in the art, includes means for generating a VCO signal having a frequency that varies as a function of the magnitude of a control voltage applied to the voltage-control input.
In operation, the charge-pump circuit is coupled to the first capacitor of the operational amplifier and pumps a discrete charge off of the first capacitor under control of the frequency of the VCO signal. An electrical current applied to the first capacitor, e.g., from the output of the sensor, tends to cause a charge to accumulate on the first capacitor as a function of the magnitude of the electrical current, which charge tends to increase the output voltage of the operational amplifier so as to increase the frequency of the VCO signal. This increased VCO frequency, in turn, causes the charge to be pumped off of the first capacitor at an increased rate. The operational amplifier thereby forces the frequency of the VCO signal to whatever rate is needed to maintain the charge on the first capacitor at essentially zero. In this manner, the frequency of the VCO signal varies as a function of the magnitude of the electrical current applied to the first capacitor.
Advantageously, in a preferred embodiment, the operational amplifier, VCO and charge pump circuit all operate using just one supply voltage having a first terminal V+, and a second terminal V- (which two terminals may sometimes be referred to as simply V and "ground") . The first capacitor is connected between a first input terminal of the operational amplifier and V- , and a second input terminal of the operational amplifier is also connected to V- . Using one supply voltage in this manner keeps the power consumption of the current- to-frequency converter very low. For example, in a preferred design, the low power current-to-frequency converter circuit consumes less than about 600 nanoamps (na) of current .
In accordance with yet another aspect of the invention, the I-to-F converter circuit may be included within the hermetically-sealed part of an implantable sensor that includes both a non-hermetically sealed part (containing, e.g., electrodes, connection terminals, and/or sensor materials that must be in contact with body fluids or tissue) and an hermetically sealed part (containing electrical circuitry to manage, monitor and/or control the non-hermetically sealed part) . A first pair of terminals is included as part of the non- hermetically sealed part and functions as the input/output terminals for connecting the implantable sensor to an implantable medical device over a connection bus that includes just two conductors, one conductor being connected to each terminal. Both operating power and control data are transmitted over the two-conductor bus from the medical device to the sensor; and sensed data, converted to a suitable form for transmission by the I-to-F converter of the present invention, is transmitted over the same two-conductor bus from the implantable sensor to the medical device. The first pair terminals (or a second pair of terminals electrically connected to the first pair of terminals) , may also function as connection terminals for attaching additional implantable sensors to the connection bus, in daisy-chain fashion, as disclosed in applicant's copending patent, entitled DAISY-CHAINABLE SENSORS AND STIMULATORS FOR
IMPLANTATION IN LIVING TISSUE, Serial No. , filed (Attorney Docket No. 56287) .
It is thus a feature of the present invention to provide a very low power, implantable, current-to- frequency conversion circuit for use within an implantable sensor, e.g., an implantable glucose sensor, that generates a small analog electrical current as a function of a sensed physiological parameter or substance .
It is another feature of the invention to provide a very low power, implantable I-to-F converter circuit that accumulates input current (I) on a storage capacitor, generates a control voltage as a function of the charge on the storage capacitor, drives a VCO with the control voltage so as to produce a VCO output signal having a frequency (F) that varies as a function of the control voltage, and pumps a discrete charge off of the first capacitor under control of the frequency of the VCO signal so as to maintain the charge on the first capacitor at approximately zero, thereby converting input current (I) to an output frequency (F) .
It is yet another feature of the invention to provide an implantable sensor having an hermetically sealed part and a non-hermetically sealed part, with electrical feed-through means for making electrical connections between the hermetically sealed part and the non-hermetically sealed part, and with a low power I-to-F converter circuit being included in the hermetically- sealed part .
Brief Description of the Drawings
The above and other aspects, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:
FIG. 1 is a block diagram that illustrates multiple sensors/stimulators connected together using a two-conductor bus, which two-conductor bus may be connected to a controller;
FIG. 2 schematically illustrates a preferred manner of how a sensor made in accordance with the present invention may be connected with a controller and other sensors in a serial or daisy-chain fashion;
FIG. 3A shows a perspective, partially exploded, view of a sensor of the type used in the daisy chain of FIG. 2;
FIG. 3B illustrates a sectional side view of the sensor of FIG. 3A;
FIG. 3C illustrates a sectional top view of the sensor of FIG. 3A;
FIG. 3D illustrates a sectional end view of the sensor of FIG. 3A; FIG. 4 depicts an implantable lead that includes a plurality of the sensors of FIGS. 3A-3D;
FIG. 5A is a functional block diagram of a simple daisy-chainable implantable sensor that includes an I-to-F converter circuit in accordance with the present invention;
FIG. 5B is a functional block diagram as in FIG. 5A, but wherein an alternate connection scheme is used for attaching additional sensors;
FIG. 5C is a functional block diagram as in FIG. 5A, but wherein additional circuit functions are provided so that a wide variety of different sensors and a stimulator may be included within the same implantable sensor device, and wherein multiple I-to-F converter circuits are included as part of the device;
FIG. 6 is a timing diagram that illustrates input and output data sent to and received from an implantable sensor of the type shown in FIG. 5A, 5B or 5C;
FIG. 7 illustrates a data frame used to communicate with the implantable sensor of the present invention;
FIG. 8 is a timing diagram that illustrates time multiplexed input and output data within a data frame as it appears on the two-conductor bus connecting a plurality of daisy-chainable devices of the type shown in FIG. 5A, 5B or 5C;
FIG. 9 shows a functional block diagram of a I-to-F converter circuit made in accordance with the present invention;
FIG. 10A shows a schematic diagram of the OP AMP portion of the I-to-F converter circuit shown in FIG. 9; FIG. 10B shows a schematic diagram of the VOLTAGE BUFFER and CHARGE PUMP portions of the I-to-F converter circuit shown in FIG. 9;
FIG. IOC shows a schematic/logic diagram of the VCO portion of the I-to-F converter circuit shown in FIG. 9; and
FIG. 10D shows a timing waveform diagram associated with the operation of the VCO circuit of FIG. IOC.
Corresponding reference characters indicate corresponding components throughout the several views of the drawings; and a generic reference to "FIG. 3", "FIG. 5" or "FIG. 10" refers respectively to all of the figures associated with that number, i.e., a generic reference to "FIG. 3" refers to all of FIGS. 3A, 3B, 3C and 3D; a generic reference to "FIG. 5" refers to all of FIGS. 5A, 5B and 5C; and a generic reference to "FIG. 10" refers to FIGS. 10A, 10B, IOC and 10D.
Detailed Description of the Invention
The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims .
The present invention relates to a very low power current-to-frequency (I-to-F) converter circuit, described more fully below in connection with FIGS. 9-10.
It is the purpose of the I-to-F converter circuit to convert an analog input signal, i.e., a very low amplitude electrical current, to a variable frequency output signal. Such output signal has a frequency that varies as a function of the magnitude of the analog input current .
The I-to-F converter circuit provided by the present invention is especially well suited for use within an implantable sensor of the type described in connection with FIGS. 1-8. It is to be understood, however, that the invention is not limited to use only within sensors of the type described in connection with in FIGS. 1-8; rather the sensors and sensor systems of the type described in connection with FIGS. 1-8 merely represent the best mode currently contemplated for using an I-to-F converter circuit within an implantable sensor.
Because a thorough understanding of such sensors should not be necessary to appreciate and understand the salient features of the I-to-F converter circuit described herein, but because a general understanding of such sensors may help provide useful background information to one way the invention may be used, only a cursory explanation of FIGS. 1-8 will be provided herein. A more thorough description of each of FIGS. 1-8 may be found in applicant's copending patent application entitled: DAISY- CHAINABLE SENSORS AND STIMULATORS FOR IMPLANTATION IN LIVING TISSUE, Serial No. , filed
(Attorney Docket No. 56287) , incorporated herein by reference.
Turning then, first to FIG. 1, there is shown a block diagram that illustrates multiple sensors 12a, 12b,
... 12n , or other implantable devices, connected together, as well as a controller (not shown in FIG. 1) using just two common conductors 14 and 16. The two conductors 14 and 16, commonly referred to as a two- conductor connection "bus", provide a common signal and return for data signals and power signals that are sent from the controller to the devices 12a, 12b, ... 12n, as well as a common signal and return path for data signals transmitted from the devices 12a, 12b, ... 12n, to the controller.
FIG. 2 schematically illustrates how an implantable sensor/stimulator 18a be connected with a remote controller 20 and other implantable devices 18b, ... 18n, in a serial or daisy-chain fashion. As seen in
FIG. 2, the device 18a is connected to the controller 20 by two conductors 14' and 16' of the connection bus, which are attached to a first pair of pads or terminals 13 and 15 along a proximal side (i.e, the side closest to the controller 20) of the device 18a. Another pair of pads or terminals 17 and 19 are located along a distal side (i.e., the side farthest from the controller 20) of the device 18a. The distal pad 17 is electrically connected to the proximal pad 13 through the circuitry 21 located on the device 18a. Similarly, the distal pad 19 is electrically connected to the proximal pad 15 through the circuitry 21 included within the device 18a. Two additional conductors 14" and 16" are then used to connect the distal pads 17 and 19 of the device 18a to corresponding proximal pads 13' and 15' of the next device 18b connected in the daisy chain. In this manner, as many devices as desired may be serially connected to the controlled 20 using just two conductors.
There exist many different applications for the daisy-chainable sensors 12 or 18 illustrated in FIGS. 1 or 2. Generally, where the sensor 12 or 18 is implanted, it is designed to sense one or more body parameters or substances found in body tissue or fluids, e.g., glucose level, blood pH, 02, temperature, or the like. Such measurements can provide valuable information regarding the condition and status of the patient.
Turning next to FIGS. 3A, 3B, 3C and 3D, there are shown, respectively, a perspective exploded view (FIG. 3A) , a side view (FIG. 3B) , a top view (FIG. 3C) , and an end view (FIG. 3D) , of a typical implantable sensor device 30 of a type suited for use with the present invention. As seen best in FIG. 3A, the sensor device 30 typically includes a carrier or substrate 36 on which an integrated circuit (IC) 38 and other components, such as a capacitor 40, are mounted. In some embodiments, it should be noted that the carrier or substrate 36 may actually comprise the substrate on which the IC 38 is fabricated; but for purposes of the explanation which follows, it is assumed that a separate substrate or carrier 36 is employed with various circuit elements mounted thereon to form a hybrid circuit. The carrier or substrate has conductive patterns etched or otherwise deposited thereon to interconnect the IC 30, capacitor 40, and any other components to form a hybrid circuit which carries out the desired sensing (or other) function.
All of the components of the hybrid circuit are hermetically sealed within a cavity formed by a lid or cover 42 which is bonded to the substrate 36. Proximal pads or terminals 13 and 15, as well as distal pads or terminals 17 and 19, remain outside of the hermetically sealed part of the hybrid circuit. These proximal and distal pads, however, are electrically connected to the circuitry within the hermetically sealed part through suitable feedthrough connections . One manner of making such feedthrough connection is to use a feedthru connection that passes through the carrier or substrate in the stair-step manner (including both vertical and horizontal segments) disclosed in co-pending patent application, Serial Number 08/515,559, filed 08/16/95, entitled "Hermetically-Sealed Electrical Feedthrough For Use With Implantable Electronic Devices", which application is assigned to the same assignee as is the instant application, and which application is incorporated herein by reference.
On the side of the carrier or substrate opposite the hybrid electrical circuitry, a suitable electrochemical sensor 44, or other desired type of sensor or stimulator, may be formed or located. A type of electrochemical sensor that may be used, for example, is the enzyme electrode sensor described in U.S. Patent No. 5,497,772, incorporated herein by reference, and in particular, in FIGS. 2A, 2B, 2C, 3, 4A and 4B of that patent .
For purposes of the present invention, the precise nature of the sensor 44, or other implantable element used within the device 30, is not critical. All that matters is that the sensor or other element be implantable, and that it provide a desired function, e.g., sense a certain type of parameter of substance, or generate a certain type of signal, in response to an appropriate control signal or signals.
Signal communication between the hybrid circuit side of the substrate or carrier 36 (which is the top side as the device 30 is oriented in FIG. 3B or FIG. 3D, and which top side includes the hermetically sealed portion of the device) and the sensor side of the device 30 (which is the bottom side as shown in FIG. 3B or 3D) is achieved by way of appropriate hermetically-sealed feedthroughs that pass step-wise from the hybrid (top) side of the device 30 through the substrate or carrier, e.g., in the manner set forth in the above-referenced '559 patent application.
The configuration illustrated in FIG. 2 is especially well-suited where several of the implantable devices are to be daisy-chained together to form a single lead 32, as shown in FIG. 4. As seen in FIG. 4, three sensor-type devices 30a, 30b, and 30c are connected together via lead segments 46a, 46b, and 46c. Each of the lead segments 46a, 46b, and 46c, contain two conductors 14, 16, and may be constructed in any suitable manner, e.g., with the two conductors being spirally wound within the lead segments, and with the spiral windings being encased or covered within a sheath of silicone rubber, as is known in the lead art. A distal cap 34 covers the distal pads of the end, or most-distal, device 30c of the lead 32.
The low power current-to- frequency converter circuit of the present invention may be included as part of the electrical circuitry contained within or included as a part of what is referred to above as the "hybrid circuit portion" of the implantable device 30. In general, such electrical circuitry allows the implantable device 30 to be daisy chained with other similar implantable devices, while still allowing each individual device to be individually addressed, controlled and monitored from a single controller 20. In particular, the I-to-F converter circuit of the present invention converts low level analog signals obtained from the sensor 44, or elsewhere, to be converted to a frequency, which frequency can then be easily counted over a fixed time period to create a digital signal representative of the sensor's analog output. Such digital signal can thereafter be more reliably transmitted over the two- conductor bus to the controller 20.
The circuitry included within the hermetically- sealed portion of the device 30 may take many and varied forms. FIGS. 5A, 5B and 5C show three such variations. FIG. 5A, for example, is a functional block diagram of a basic configuration of control/interface circuitry 50 for use with a sensor 52. The dotted line 54 represents an hermetic seal that hermetically seals the circuitry 50 and all but a portion of the sensor 52. The input pads 13 and 15, as well as the output pads 17 and 19, are not hermetically sealed, thereby allowing these pads to be readily connected to the two conductors 14 and 16 (FIG. 1) from the controller 20.
As seen in FIG. 5A, pads 13 and 15 are connected to respective conductive traces, labeled LINE 1 (IN) and LINE 2 (IN) , representing the two conductors of the two-conductor bus that connects the device 30 to its controller 20, or to other devices. Each of the LINE 1 and LINE 2 conductive traces passes through respective feedthroughs 53 and 55 into the hermetically sealed portion of the circuitry 50. Pads 17 and 19, on the other side of the circuit, are likewise connected to respective conductive traces, labeled LINE 1 (OUT) and LINE 2 (OUT) , and each of these conductive traces passes through respective feedthroughs 57 and 59 into the hermetically sealed portion 54 of the circuitry 50. Inside the hermetically sealed portion, LINE 1 (IN) connects with LINE 1 (OUT) via conductive trace 56, and LINE 2 (IN) connects with LINE 2 (OUT) via conductive trace 58. In this manner, pad 13 is electrically connected with pad 17 via trace 56 which passes through the hermetically sealed portion 54 between feedthroughs 53 and 57. This interconnection of pad 13, trace 56 and pad 57 is referred to hereafter simply as LINE 1. Similarly, pad 15 is electrically connected with pad 19 via trace 58, which trace also passes through the hermetically sealed portion 54 between feedthroughs 55 and 59. This interconnection is referred to hereafter as LINE 2.
As seen in FIG. 5A, a power rectifier circuit 60 is connected between LINE 1 and LINE 2. This circuit extracts and rectifies any signal pulses found on LINE 1 and LINE 2 and produces an operating voltage, +V and -V, for powering the circuitry 50. Such rectification is not a trivial task given the low level signals which are generally present on LINE 1 and LINE 2, which signals are usually well below the 0.6-0.8 voltage drop of a conventional silicon diode. Details of such circuitry may be found in copending patent application A LOW POWER
RECTIFIER CIRCUIT FOR IMPLANTABLE DEVICES, Attorney
Docket No. 57795, previously incorporated herein by reference .
A line interface circuit 62 also is connected between LINE 1 and LINE 2. The circuit 62 functions as an interface between the circuitry 50 and LINE 1 and LINE 2. To this end, the interface circuit 50 receives incoming data pulses present on LINE l/LINE 2 and generates a DATA-IN signal on line 64 therefrom. The interface circuit 62 further generates a clock (CLK) signal on line 66 that is synchronized with the incoming data signals. The interface circuit 50 also receives digital output data, DATA OUT, from a counter circuit 68, and converts this output data to an appropriate format prior to placing the output data back on LINE l/LINE 2. One type of line interface circuit 62 that may be used with the circuitry 50 is illustrated in the schematic diagram shown and explained below in conjunction with FIG. 9.
Still referring to FIG. 5A, the sensor 52 may be any suitable sensor adapted to sense a desired condition, parameter, or substance present (or absent) in the implantable tissue within which the device 30 is implanted. For example, the sensor 52 may comprise a glucose sensor that generates an output analog current, I, appearing on line 69, having a magnitude that varies as a function of the sensed glucose.
As a practical matter, regardless of the type of sensor 52 that is employed, it will usually generate either an analog output voltage or an analog output current as a function of the concentration, magnitude, composition, or other attribute, of the parameter being sensed. Such analog current or voltage may then be converted, using an appropriate converter circuit 70, to a frequency signal, appearing on line 72. Typically, the frequency signal on line 72 comprises a train of pulses having a frequency (or repetition rate) that varies as a function of the input voltage or current. In FIG. 5A, for example, it is assumed that the sensor 52 generates an output current I, and that the converter circuit 70 comprises a current-to- frequency (I-to-F) converter circuit, generating an output pulse train on line 72 that has a frequency which varies as the magnitude of the current J varies. It is this I-to-F converter circuit
70, or an equivalent converter circuit, that comprises the subject matter of the present invention.
Once a pulse train 72, or other ac signal, is generated having a frequency which varies as a function of the parameter being sensed by the sensor 52, such signal is applied to a counter circuit 68. (Note, as a shorthand notation used in this application, a signal appearing on signal line having a given reference number may be referred to as the signal having such given reference number, i.e., the signal appearing on signal line 72 may simply be referred to as "signal 72".) The counter circuit simply counts the number of pulses present in the signal 72 over a prescribed period of time, e.g., a fixed time window of 1 second, thereby providing a measure of the frequency of the signal 72. In this manner, by resetting the counter 68 at the beginning of each measurement period, the count held in the counter at the end of the measurement period provides a signal representative of the frequency of the signal 72. Such count signal, for the basic embodiment shown in FIG. 5A, may thus serve as the output data signal, DATA OUT, that is sent to the line interface circuit 62 over signal line 74.
Control of the counter 68, i.e., resetting the counter and/or stopping the counter after a prescribed measurement period, is controlled by control logic 76. In a simple embodiment, the measurement period may be a fixed time period. In other embodiments, the measurement period may be set by input data received over signal line 64 from the line interface circuit 62. The clock signal 66 may be used as a measure of elapsed time, as well as to coordinate when the counter 68 sends its DATA OUT signal 74 to the line interface circuit 62.
As needed, a voltage generator circuit 78 generates a reference voltage VREP, and one or more bias signal (s) , VBIAS, that are used by the current-to- frequency (I-to-F) converter circuit 70 as it performs its function of converting the analog current signal 69 to a frequency signal 72, as explained more fully below in connection with FIGS. 9 and 10.
In a similar manner, one or more I-to-F converter circuits may be used within the devices illustrated in FIGS. 5B and 5C, as described in the above-referenced copending patent application, entitled: DAISY-CHAINABLE SENSORS AND STIMULATORS FOR IMPLANTATION IN LIVING TISSUE.
Turning back momentarily to FIG. 2, where a plurality of implantable, daisy-chainable sensors 18a, 18b ...18n are shown connected in tandem, a preferred manner of operation is for the controller 20 to provide operating power to, as well as to individually address and send data to and receive data from, each of the devices 18 that are connected thereto over the two- conductor bus made up of the conductors 14 and 16. One manner in which such powering and individual addressing is done is as shown in connection with FIGS. 6, 7 and 8. FIG. 6 illustrates, for example, a timing diagram that shows a preferred relationship between input data (top waveform) sent to the implantable devices and output data (bottom waveform) received from the implantable devices, as such data appears on the two LINE l/LINE 2 conductors that connect all of the devices together. As seen in FIG. 6, the preferred form for the input data is biphasic pulses. Each biphasic pulses comprises a first current pulse of a first polarity, followed by a second current pulse of the same magnitude of the opposite polarity. Thus, the net current for each biphasic pulse is preferably zero, with the positive current pulse effectively balancing out the negative current pulse.
The typical widths of the current pulses are from to msec, with the magnitude of each current pulse typically ranging from to microamps . A binary or logical "1" is represented by a biphasic pulse of one phase, e.g., a positive current pulse followed by a negative current pulse; while a binary or logical "0" is represented by a biphasic pulse of the opposite phase, e.g., a negative pulse followed by a positive pulse. Thus, as shown in FIG. 6, a binary "1" may be represented as a positive current pulse followed by a negative current pulse, while a binary "0" is represented by a negative current pulse followed by a positive current pulse .
As also seen in FIG. 6, the preferred form for the output data is also a biphasic pulse, amplitude modulated (or preferably ON/OFF modulated) as a function of whether the output data is a binary "1" or "0". In a preferred embodiment, the peak amplitude of the output data pulse for a binary "1" is Ip/ while the peak amplitude of the output data pulse for a binary "0" is zero. Thus, in this preferred ON/OFF modulation scheme, the presence of an output data pulse represents a binary "1" and the absence of an output data pulse represents a binary "0". Output data pulses are inserted in the data stream appearing on the LINE l/LINE 2 conductors pulses at a specified time T2 from the input data pulse so as to fall between the input data pulses, in a time-division multiplexed manner. Although the preferred form of the output data pulses is a biphasic pulse (to achieve current balancing) , it is noted that in some instances a monophasic pulse at time T2 (and with amplitude of Ip or zero) may be used.
As shown in FIGS. 7 and 8, the input data sent over the LINE l/LINE 2 conductors by the controller is divided into data frames of length T3. Within each data frame, N bits of data are found, where N is an integer typically ranging from 8 to 64. A representative assignment of the data bits included in the data frame is illustrated in FIG. 7.
Because the input data comprises biphasic pulses that occur at a regular interval or rate (e.g., every Tl seconds) , the energy contained in such pulses may be utilized to provide the operating power for the circuits contained within the device 50". Such is accomplished using the rectifier circuit 60, 60' or 60" (FIGS. 5A, 5B or 5C) .
The input and output data pulses of the type shown in FIGS. 6 and 8 are generated by the line interface circuit 62, 62' or 62" (FIGS. 5A, 5B or 5C) . A schematic diagram of a preferred line interface circuit is described in the above-referenced copending patent application, Attorney Docket No. 56287 (see particularly FIG. 9 of the referenced application, and its accompanying text) .
With reference next to FIG. 9, there is shown a block diagram of a low power current-to-frequency converter circuit 150 made in accordance with the present invention. As seen in FIG. 9, the current-to-frequency converter 150 includes four main functional elements. These four main functional elements include: (1) an operational amplifier 152 having a positive input terminal 153a and a negative input terminal 153b, and an output terminal 154; (2) a capacitor C4 connected to the positive input terminal 153a of the operational amplifier 152; (3) a voltage controlled oscillator (VCO) circuit 156 having a voltage-control input terminal and a VCO output terminal, the VCO input terminal being connected to the output terminal 154 of the operational amplifier 154, and the VCO output terminal providing a variable frequency output signal Fouτ; and (4) a charge-pump circuit 158 coupled to capacitor C4 (i.e., also connected to positive input terminal 153a of the operational amplifier 152.
In operation, the analog input signal, JIN, charges up the capacitor C4. The amount of charge accumulated by capacitor C4 is a function of the magnitude of the input current I1N, which input current reflects a measure of the parameter or other condition being sensed by the sensor or otherwise monitored from within the implantable device 30. The charge pump circuit 158 pumps a discrete charge (i.e., a fixed number of coulombs) off of capacitor C4 during each cycle of the Fom signal generated by the VCO 156. The operational amplifier 152 differentially amplifies an electrical signal applied between its two input terminals 153a and 153b to produce an amplified output signal on its output terminal 154. Because, the negative input terminal 153b is grounded, the differential input signal applied to the operational amplifier 152 is effectively the amount of charge, or voltage, that has accumulated on the capacitor C4. Thus, the amplified output signal from the operational amplifier 152 comprises a voltage that varies as a function of the input current IIN. This amplified output signal is applied to the VCO 156 as a control voltage, causing the frequency output signal, Fouτ, of the
VCO to have a frequency that varies as a function of the input current, JIN.
The output frequency signal from the VCO, Fouτ, besides being available as an variable frequency output signal Fouτ that can be counted over a fixed period of time (as described above in connection with FIG. 5A) , is also applied to the charge pump circuit 158. This output frequency signal Fouτ typically comprises a pulse train, the frequency of which varies as a function of the magnitude of a voltage applied to the voltage-control input. For each pulse of the variable frequency pulse train Fouτ, the charge pump circuit 158 pumps a discrete charge off of the capacitor C4. Thus, it is seen that the input current JIN causes a charge to accumulate on capacitor C4 , which charge tends to increase the output voltage of the operational amplifier 152 so as to increase the frequency of the Fouτ output signal. This increased frequency, in turn, causes the charge that is pumped off of the capacitor C4 to increase (or to occur at an increased rate) . The net result is that the operational amplifier 152, by amplifying the charge accumulated on capacitor C4 in this manner, forces the frequency of the Fouτ signal to whatever rate is needed to maintain the net charge on the capacitor C4 at essentially zero. As a result, the frequency of the Fouτ signal varies as a function of the magnitude of the electrical current IIN applied to the capacitor C4 , and the desired current-to-frequency (I-to-F) conversion is thus achieved. As needed, and as explained more fully below in connection with FIG. 10, a voltage buffer circuit 160 may be employed as part of the I-to-F conversion circuit 150 of FIG. 9 to produce a stable and isolated reference voltage VREP, which reference voltage is used by the charge pump circuit 158 as it performs its charge pumping function.
While less elaborate I-to-F converter circuits than the circuit 150 of FIG. 9 could and have been devised by those of skill in the art, the advantageous feature of the I-to-F circuit 150 of FIG. 9 is that it can be configured, using low power FET transistors, to operate so as to consume very little power. Such a low power configuration is shown and described below in connection with FIGS. 10A, 10B, 10C and 10D.
Turning next, then, to FIGS. 10A, 10B, 10C, and 10D, schematic and/or logic diagrams of a preferred low power I-to-F converter circuit made in accordance with the best mode presently contemplated for practicing the invention is illustrated. The I-to-F converter circuit 150 is preferably realized using a miniature integrated circuit (IC) , configured, e.g., with specific combinations of N-channel and P-channel field effect transistors (FETs) , denoted as "N-FET" and "P-FET" transistors, formed on a common substrate, and specifically designed for low power consumption. The preferred sizes (length and width) of each of the relevant N-FET or P-FET transistors are listed in Table 1, along with other component values of interest. The N-FET and P-FET dimensions shown in Table 1 relate to the relative size of each transistor as it is formed on the IC substrate. More particularly, an N-FET, for example, having a size of "5/10" means that [***John: please add a sentence or two that describes what these values mean.**] This type of characterization (by dimension or size) of the various N-FET and P-FET transistors used within an IC is known and understood by those of skill in the semiconductor processing art. Advantageously, by selectively controlling the size (dimensions) of such transistors during the IC processing steps, the performance of the FET transistors can be controlled or tailored for the specific design for which the transistor is used. Thus a relatively "long" N-FET, having a size of, e.g., 5/10, may exhibit a higher turn-on resistance (and hence a slower turn on time) than would, e.g., a relatively "short" N-FET, having a size of 4/4.
TABLE 1
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
In general, as is known in the art, a FET transistor has three terminals, a "source", a "drain" and a "gate". The voltage applied to the gate terminal controls the conductivity of the semiconductor channel that connects the source and drain terminals. By controlling the conductivity of the source-drain channel, the amount of current that flows through the channel can be controlled, from zero current to a maximum current (determined by the ON resistance and the available voltage drop across the channel) . A common use for a FET transistor is as a switch. When used as a switch, the conductivity of the source-drain channel, as controlled by the voltage applied to the base terminal, is either very low (the FET switch is ON) or very high (the FET switch is OFF) . For the types of FETs used in the circuits of FIGS. 10A, 10B and IOC, a high voltage applied to the gate of a P-FET tends to turn the P-FET "OFF"; whereas a high voltage applied to the gate of an N-FET tends to turn the N-FET "ON". In FIGS. 10A, 10B, and IOC, an N-FET is depicted in classical FET form, i.e., appearing generally as a forward or backwards block letter "C", made up of three segments, with one end of one segment of the "C" comprising the "source", and with one end of another segment of the "C" (which end is marked with a heavy dot nearby) comprising the "drain" . The "gate" is depicted as a short line that is parallel to, but not touching, the middle segment of the "C" . A P-FET is depicted the same as an N-FET except that a diagonal line is drawn through the "C" .
A preferred operational amplifier (OP AMP) 152 is shown schematically in FIG. 10A. P-FET M10 is biased by a external voltage reference signal BIASP so as to form a constant current source of a few nanoamps to a differential pair of transistors Mil and M12. So long as the base voltage applied to each of the differential pair Mil and M12 is equal, the current from the current source M10 is equally split between Mil and M12. N-FETs M13 and M14 are permanently biased ON to provide a current mirror, which in effect functions as a fixed load resistance for the differential pair Mil and M12. The base terminal of Mil is connected to one side of a storage capacitor C4. The other side of the capacitor C4 is grounded (connected to V-) . The base terminal of M12 is connected to ground (V-) . The input terminal of the OP AMP 152 comprises the gate of Mil. Hence, any input current, IIN, that flows into the OP AMP, begins to charge up C4 , causing a voltage to appear at the gate of Mil that is different than the voltage applied to the gate of M12. Because transistor Mil is a P-FET transistor, a higher gate voltage (as would occur when an input current IIN starts to charge capacitor C4) tends to turn Mil OFF (increases its resistance) . This increase in resistance, in turn, causes the constant current from the current source M10 to be unevenly split between the two M11/M12 paths. More particularly, an increase in the input voltage applied to the gate of Mil (caused by applying an input current IIN so as to charge up the capacitor C4) causes an increased current to flow through the M12 leg of the OP AMP, thereby causing the output voltage, Vouτ (which is the voltage at the drain of M12) , on signal line 154, as measured relative to ground (V- ) , to increase. By properly selecting the value of the effective load resistance (M14) in the M12 leg of the OP AMP, and assuming given performance characteristics for the M11/M12 transistor pair, the "gain" of the OP AMP (where "gain" is defined, for purposes of the OP AMP shown in FIG. 10A, as the ratio of V0UT/VIN, where VIN is the voltage developed on the capacitor C4 by the current IIN) can thus be made sufficiently large, e.g., up to , to support the desired overall operation of the
I-to-F circuit.
With the inputs of the M11/M12 differential pair being maintained at or near zero, and with the combination of the threshold BIASP plus the voltage applied to the body (or substrate) of the P-FETS (which is typically V+ , or about 3 volts) , the output voltage Vouτ of the OP AMP 152 may swing from near ground (V-) to about 1.5 volts. A capacitor C3 is connected between the output terminal of the OP AMP (drain of M12) and filters this output voltage to a desired extent.
The output voltage Vouτ from the OP AMP 152 (FIG. 10A) , on signal line 154, is applied to the control voltage input of the VCO 156. A schematic/logic diagram of a preferred low power VCO is illustrated in FIG. IOC, and a timing waveform diagram that illustrates the basic operation of the VCO 156 is shown in FIG. 10D. For simplicity, gates 162 through 174 included in the low power VCO of FIG. IOC (which are configured as a cross- coupled latch with active-high inputs) are shown in logic diagram form. It is to be understood, however, that such gates are preferably configured using additional N-FET and P-FET transistors, as is known in the art.
The operation of the VCO is best understood by considering what happens just after the output of gate 172 (identified in FIG. IOC and 10D as CLKB) goes high. This turns off M15 and allows the drain of M15 (which is the same point as the drain of Ml6) to ramp toward ground (V-), as seen in FIG. 10D. The slope of the ramp depends on the capacitance on the drain node and on the drain current (and hence gate voltage) of M16. When the drain voltage of M15/M16 ramps down to about one threshold below V+, P-FET M21 turns ON, causing an input of gate 164 to go positive over signal line 176 (FIG. IOC) . As the logic threshold of gate 164 is reached, the output of gate 164 goes low, turning on M24 (via signal line 178) . This action provides hysteresis by reinforcing the high-going signal at the input of gate 164 (via signal line 176) . A short time later, the output of gate 164 reaches the logic threshold of gate 170, and the latch (i.e., the cross-coupled latch with active-high inputs made up of gates 162-172) flips state.
Once the state of the cross-coupled latch has switched, the output of gate 172 goes low, and the output of gate 168 (CLKA) goes high, and the sequence repeats, but with M18, M25, and gate 162 in the signal path. During this repeat time, the drain of M15/16 remains high, while the drain of M18 (which is the same point as the drain of Ml9) ramps toward ground (V- ) at a rate that depends on the capacitance on the drain node and on the drain current of (and hence the drain voltage) of M19. As seen in FIG. 10D, this results in the generation of two complimentary clock signals, CLKA and CLKB, with an output signal Fouτ being derived from the CLKB signal, as buffered by inverter gate 174.
During the operation described above, N-FETs M17 and M20 function as current sources that limit the capacitance charging current in the VCO to about 50 na . Such limiting prevents a lockup conduction which would otherwise occur if the VCO attempted to operate above its normal maximum frequency. In operation, the nominal frequency of the VCO 156 is about KHz, with a typical minimum operating frequency of KHz, and a typical maximum operating frequency of KHz.
It is noted that the frequency versus voltage relationship of the VCO shown in FIG. IOC is not linear (since it depends on the drain current versus gate voltages of N-FETs M16 and M19) . However, as evident from the description of the operation of the complete I-to-F converter, the overall current-to-frequency linearity depends only on the repeatability of the charge pump, and that is designed, as explained below, to pump a fixed charge of about 6 picocoulombs (pC) with every flip of the VCO.
One special feature associated with the VCO 156 shown in FIG. IOC is that the NOR gates 162 and 164 each include a series bias FET that limits the supply current to less than 100 na when the logic inputs are at voltages between the supply rails, i.e., between V+ and V- .
It is the CLKA and CLKB signals that drive the charge pump circuit 158, shown in the bottom half of FIG. 10B. The charge pump circuit 158 includes eight N-FET transistors, Ml through M8. In operation, the charge pump circuit emits fixed size packets of charge to the circuit input node, over signal line 180. The amount of charge is determined by the value of capacitors Cl and C2 and by a reference voltage VREF. The reference voltage VREF comprises a buffered reference voltage that is generated by the voltage buffer circuit 160, shown in the upper half of FIG. 10B. Other reference voltages used by the I-to-F converter circuit 150 include an unbuffered reference voltage VR, a BIASP reference voltage, and a BIASN reference voltage. The BIASP reference voltage includes a current limiter (i.e., a pullup resistor) in series therewith that limits the current from the BIASP reference to less than about 100 na.
The operation of the charge pump circuit 158 is as follows: during one state of the VCO, i.e., when CLKA is low and CLKB is high, M3 and M4 are ON, and Ml and M2 are OFF. In this condition, capacitor Cl charges to the reference voltage, VREF. When the VCO state flips, i.e., when CLKA goes high and CLKB goes low, M3 and M4 turn OFF, and then Ml and M2 turn ON. This then causes Cl to discharge via signal line 180 (which is connected to the input of the OP AMP 152) , causing the otherwise high- going input signal line (recall that input current IIN is charging capacitor C4) to be pulled back towards ground (V-) .
The second capacitor C2 works in tandem with the first capacitor Cl . That is, while capacitor Cl is charging up to VREF, capacitor C2 is discharging via signal line 180 back to ground (V-) . While capacitor C2 is charging up to VREF, capacitor Cl is discharging via signal line 180 back to ground. Each time that Cl or C2 discharges, it pulls charge off of the input capacitor C4 via signal line 180. The net result is that the I-to-F converter maintains the input terminal 153a of the OP AMP 152 at the same potential as the input 153b, which is V- (ground) . Thus, it is seen that with each flip of the VCO, a charge packet is pumped off of the input capacitor C4. Since these charge packets are the only current flowing from the sensor, and since they are all the same size, their frequency is directly related to the input current IIN.
The sizes of the various FETs used within the charge pump circuit 158, and the VCO 156, are chosen so that the capacitors Cl and C2 are fully charged and discharged during each phase of the VCO operation, even at the highest frequencies of normal operation. The timing of the two VCO outputs, CLKA and CLKB, ensures a break-before-make action on the switches connected to the charge pump capacitors Cl and C2.
In summary, all of the sensor current I1N that is collected by capacitor C4 is pumped off of the capacitor C4 by the charge pump circuit . As soon as the input current IIN tries to pull the circuit input 153a away from ground, the OP AMP output causes the VCO to speed up, which in turn causes more negative-going charge packets to be emitted by the charge pump 158, which pulls the circuit input 153a back to ground.
In order to prevent cross talk due to transient loading of VREF, the voltage buffer circuit 160 is employed. Such buffer circuit comprises, as seen in the upper half of FIG. 10B, a conventional OP AMP follower circuit composed of FET transistors M29-M35.
The overall power consumption of the I-to-F converter circuit described in connection with FIG. 10 is only about 1.8 picowatts (assuming a 3 volt operating voltage, and 600 na operating current) . The quiescent operating current of the device is less than about 100 na. Such low power operation is one of the salient features of the I-to-F converter circuit of the present invention. Another important feature of the invention is that the input terminal of the I-to-F converter circuit 150, which is terminal 153a of the OP AMP 152, is maintained at essentially ground potential without the necessity of a second voltage supply. That is, in a conventional OP AMP, in order to maintain the inputs at zero volts, one would have to bias the OP AMP with a voltage greater than zero, e.g., +5 volts, and a voltage less than zero, e.g., -5 volts, thereby forcing the use of two separate voltage supplies. However, by using FET transistors, as shown in FIG. 10A, it is possible to maintain the inputs at or near zero, even though the OP AMP itself is only biased with a single supply between V+ and V- (ground) .
As described above, it is thus seen that the present invention provides a low power current-to- frequency converter circuit usable, e.g., in an implantable sensor device wherein there is a need to convert a low level analog signal, such as a very small electrical dc current, the magnitude of which is representative of a sensed parameter or substance, to a digital value that can be better transmitted over a shared communication bus to a remote receiver.
While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.

Claims

CLAIMSWhat is claimed is:
1. A low power current-to-frequency (I/F) converter circuit for use within an implantable sensor device, comprising: an operational amplifier having two input terminals and an output terminal, the operational amplifier comprising means for differentially amplifying an electrical signal applied between its two input terminals to provide an amplified output signal appearing on its output terminal; a first capacitor electrically connected to at least one of the input terminals of the operational amplifier; a voltage controlled oscillator (VCO) circuit having a voltage-control input terminal and a VCO output terminal, the voltage-control input terminal being connected to the output terminal of the operational amplifier, the VCO including means for generating a frequency output signal Fouτ having a frequency that varies as a function of the magnitude of a voltage applied to the voltage-control input; a charge-pump circuit coupled to the first capacitor that pumps a discrete charge off of said first capacitor under control of the frequency output signal Fouτ generated by the VCO.
2. The low power I/F converter circuit of Claim 1 wherein the operational amplifier, VCO and charge pump circuit all operate using one supply voltage having a first terminal V+, and a second terminal V- , and wherein the first capacitor is connected between a first input terminal of the operational amplifier and V- , and a second input terminal of the operational amplifier is also connected to V- .
3. The low power I/F converter circuit of Claim 2 wherein the I/F converter circuit is made up of semiconductor circuit components that consume less than 600 nanoamps (na) of current.
4. The low power I/F converter circuit of Claim 1 further including logic circuits responsive to the Fouτ signal to control the charge pump circuit to pump the discrete charge off of the first capacitor at least once during each cycle of the Fouτ signal .
5. The low power I/F converter circuit of Claim 4 wherein the discrete charge pumped off of the first capacitor at least once during each cycle of the Fouτ signal comprises a charge no greater than about 10 pico- coulombs .
6. The low power I/F converter circuit of Claim 5 wherein the logic circuits generate a clock signal from the Fouτ signal having a first phase and a second phase, and wherein the charge pump circuit comprises means for generating a reference voltage VREF, a second capacitor, a first set of switches for charging the second capacitor to the specified reference voltage VREF during the first phase of the clock signal, and a second set of switches for connecting the second capacitor across the first capacitor with opposing polarity during the second phase of the clock signal, whereby the VREF charge that accumulates on the second capacitor during the first phase of the clock signal is pulled off of the first capacitor during the second phase of the clock signal .
7. The low power I/F converter circuit of Claim 6 wherein the charge pump circuit further includes: a third capacitor, additional switches as part of the second set of switches for charging the third capacitor to the specified reference voltage VREF during the second phase of the clock signal, and additional switches as part of the first set of switches for connecting the third capacitor across the first capacitor with opposing polarity during the first phase of the clock signal, whereby the VREF charge that accumulates on the third capacitor during the second phase of the clock signal is pulled off of the first capacitor during the first phase of the clock signal.
8. An implantable sensor comprising: a sensor that generates an analog current as a function of a substance or parameter sensed by the sensor; a current-to-frequency (I/F) converter circuit that converts the analog current generated by the sensor to a frequency signal, Fouτ, having a frequency that varies as a function of the analog current, said I/F converter circuit comprising: an operational amplifier having a positive input terminal, a negative input terminal, and an output terminal, the operational amplifier including means for differentially amplifying an electrical signal applied between its two input terminals to provide an amplified output signal that appears on its output terminal; a first capacitor connected to one of the input terminals of the operational amplifier; a voltage controlled oscillator (VCO) circuit having a voltage-control input terminal connected to the output terminal of the operational amplifier, and a VCO output terminal, the VCO including means for generating the frequency signal Fouτ as an output signal of the VCO, the signal Fouτ having a frequency that varies as a function of the magnitude of a voltage applied to the voltage-control input; a charge-pump circuit coupled to the first capacitor that pumps a discrete charge off of the first capacitor under control of the frequency of the signal F wherein an analog electrical current from the sensor applied to the first capacitor tends to cause a charge to accumulate on the first capacitor as a function of the magnitude of the electrical current, which charge tends to increase the output voltage of the operational amplifier so as to increase the frequency of the signal Fouτ, which increased frequency causes charge to be pumped off of the first capacitor at an increased rate, wherein the operational amplifier forces the frequency of the Fouτ signal to whatever rate is needed to maintain the charge on the first capacitor at essentially zero, whereby the frequency of the VCO signal varies as a function of the magnitude of the analog electrical current applied to the first capacitor.
9. The implantable sensor of Claim 8 wherein the operational amplifier, VCO and charge pump circuit all operate using one supply voltage having a first terminal V+, and a second terminal V- , and wherein the first capacitor is connected between a first input terminal of the operational amplifier and V- , and a second input terminal of the operational amplifier is also connected to V- .
10. The implantable sensor of Claim 9 further including a logic circuitry responsive to the frequency signal Fouτ generated by the VCO to control the charge pump circuit to pump the discrete charge off of the first capacitor at least once during each cycle of the Fouτ signal .
11. The implantable sensor of Claim 10 wherein the discrete charge pumped off of the first capacitor at least once during each cycle of the Fouτ signal comprises a charge no greater than about 10 pico-coulombs .
12. In an implantable medical device, a low power current-to- frequency converter comprising: an operational amplifier having two input terminals and one output terminal, the operational amplifier comprising means for differentially amplifying an electrical signal applied between its two input terminals to provide an amplified output signal appearing on its output terminal; a first capacitor connected to one of the input terminals of the operational amplifier; a voltage controlled oscillator (VCO) circuit having a voltage-control input terminal and a VCO output terminal, the voltage-control input terminal being connected to the output terminal of the operational amplifier, the VCO including means for generating a VCO signal having a frequency that varies as a function of the magnitude of a voltage applied to the voltage-control input ; a charge-pump circuit coupled to the first capacitor of the operational amplifier for pumping a discrete charge off of said first capacitor under control of the frequency of said VCO signal; wherein an electrical current applied to the first capacitor tends to cause a charge to accumulate on the first capacitor as a function of the magnitude of the electrical current, which charge tends to increase the output voltage of the operational amplifier so as to increase the frequency of the VCO signal, which increased VCO frequency causes the charge to be pumped off of the first capacitor at an increased rate, wherein the operational amplifier forces the frequency of the VCO signal to whatever rate is needed to maintain the charge on the first capacitor at essentially zero, whereby the frequency of the VCO signal varies as a function of the magnitude of the electrical current applied to the first capacitor.
13. The low power current-to-frequency converter of Claim 12 wherein the operational amplifier, VCO and charge pump circuit all operate using one supply voltage having a first terminal V+, and a second terminal V- , and wherein the first capacitor is connected between a first input terminal of the operational amplifier and V- , and a second input terminal of the operational amplifier is also connected to V- .
14. The low power current-to-frequency converter of Claim 12 wherein the current-to-frequency converter consumes less than about 600 nanoamps (na) of current.
15. The low power current-to-frequency converter of Claim 12 further including a latch logic circuit coupled to the VCO for generating a clock signal for controlling the charge pump circuit to pump the discrete charge off of the first capacitor at least once during each cycle of the clock signal.
16. The low power current-to-frequency converter of Claim 15 wherein the discrete charge pumped off of the first capacitor at least once during each cycle of the clock signal comprises a charge no greater than about 10 pico-coulombs .
17. The low power current-to-frequency converter of Claim 15 wherein the clock signal has a first phase and a second phase, and wherein the charge pump circuit comprises a second capacitor, a first set of switches for charging the second capacitor to a specified reference voltage VREF during the first phase of the clock signal, and a second set of switches for connecting the second capacitor across the first capacitor with opposing polarity during the second phase of the clock signal, whereby the VREF charge that accumulates on the second capacitor during the first phase of the clock signal is pulled off of the first capacitor during the second phase of the clock signal .
18. The low power current-to-frequency converter of Claim 17 wherein the charge pump circuit further includes : a third capacitor, additional switches as part of the second set of switches for charging the third capacitor to the specified reference voltage VREF during the second phase of the clock signal, and additional switches as part of the first set of switches for connecting the third capacitor across the first capacitor with opposing polarity during the first phase of the clock signal, whereby the VREF charge that accumulates on the third capacitor during the second phase of the clock signal is pulled off of the first capacitor during the first phase of the clock signal.
PCT/US1998/018978 1997-09-12 1998-09-11 Low power current-to-frequency converter circuit for use in implantable sensors WO1999013574A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2000511247A JP3958933B2 (en) 1997-09-12 1998-09-11 Low power current / frequency conversion circuit used for sensors that can be embedded
EP98946040A EP1012974B1 (en) 1997-09-12 1998-09-11 Low power current-to-frequency converter circuit for use in implantable sensors
AU93146/98A AU9314698A (en) 1997-09-12 1998-09-11 Low power current-to-frequency converter circuit for use in implantable sensors
CA002303022A CA2303022C (en) 1997-09-12 1998-09-11 Low power current-to-frequency converter circuit for use in implantable sensors
DE69819533T DE69819533T2 (en) 1997-09-12 1998-09-11 CURRENT FREQUENCY TRANSFORMER AND ITS USE IN IMPLANTABLE SENSORS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/928,868 1997-09-12
US08/928,868 US5917346A (en) 1997-09-12 1997-09-12 Low power current to frequency converter circuit for use in implantable sensors

Publications (1)

Publication Number Publication Date
WO1999013574A1 true WO1999013574A1 (en) 1999-03-18

Family

ID=25456908

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/018978 WO1999013574A1 (en) 1997-09-12 1998-09-11 Low power current-to-frequency converter circuit for use in implantable sensors

Country Status (7)

Country Link
US (1) US5917346A (en)
EP (1) EP1012974B1 (en)
JP (1) JP3958933B2 (en)
AU (1) AU9314698A (en)
CA (1) CA2303022C (en)
DE (1) DE69819533T2 (en)
WO (1) WO1999013574A1 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513602A (en) * 1998-04-30 2002-05-14 セラセンス、インク. Analyte monitoring system and method of use
EP1968693A2 (en) * 2005-12-22 2008-09-17 Proteus Biomedical, Inc. Implantable integrated circuit
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9320466B2 (en) 2009-07-02 2016-04-26 Dexcom, Inc. Analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US9549693B2 (en) 2002-05-22 2017-01-24 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US10376143B2 (en) 2003-07-25 2019-08-13 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10791928B2 (en) 2007-05-18 2020-10-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor

Families Citing this family (275)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6558321B1 (en) 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US7192450B2 (en) 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7657297B2 (en) * 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US6088608A (en) * 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
ATE514372T1 (en) * 1998-10-08 2011-07-15 Medtronic Minimed Inc LICENSE PLATE MONITORING SYSTEM WITH REMOTE MEASUREMENT
US7766873B2 (en) 1998-10-29 2010-08-03 Medtronic Minimed, Inc. Method and apparatus for detecting occlusions in an ambulatory infusion pump
US7621893B2 (en) 1998-10-29 2009-11-24 Medtronic Minimed, Inc. Methods and apparatuses for detecting occlusions in an ambulatory infusion pump
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US6974437B2 (en) 2000-01-21 2005-12-13 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
JP2001326567A (en) * 2000-03-10 2001-11-22 Rohm Co Ltd Mosfet driving circuit
EP1314249A2 (en) * 2000-09-01 2003-05-28 Honeywell International Inc. Multi-channel precision synchronous voltage-to-frequency converter
JP4212767B2 (en) * 2000-12-21 2009-01-21 旭化成エレクトロニクス株式会社 High-speed current switch circuit and high-frequency current source
EP1397068A2 (en) 2001-04-02 2004-03-17 Therasense, Inc. Blood glucose tracking apparatus and methods
US6792314B2 (en) * 2001-06-18 2004-09-14 Alfred E. Mann Foundation For Scientific Research Miniature implantable array and stimulation system suitable for eyelid stimulation
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6702857B2 (en) 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US6809507B2 (en) * 2001-10-23 2004-10-26 Medtronic Minimed, Inc. Implantable sensor electrodes and electronic circuitry
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20040193229A1 (en) * 2002-05-17 2004-09-30 Medtronic, Inc. Gastric electrical stimulation for treatment of gastro-esophageal reflux disease
US7519428B1 (en) 2002-06-14 2009-04-14 Advanced Bionics, Llc Dual-range compliance voltage supply for a multi-channel stimulator
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US8512276B2 (en) 2002-07-24 2013-08-20 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US20040122353A1 (en) * 2002-12-19 2004-06-24 Medtronic Minimed, Inc. Relay device for transferring information between a sensor system and a fluid delivery system
US7136704B2 (en) 2003-04-16 2006-11-14 Alfred E. Mann Foundation For Scientific Research Blood oxygen monitoring system and a lead therefor
EP2460881B1 (en) * 2003-05-16 2017-05-03 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of CNS
US7620454B2 (en) * 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7742818B2 (en) * 2003-05-19 2010-06-22 Medtronic, Inc. Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8285354B2 (en) 2003-08-01 2012-10-09 Dexcom, Inc. System and methods for processing analyte sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20070066873A1 (en) 2003-08-22 2007-03-22 Apurv Kamath Systems and methods for processing analyte sensor data
US20050075702A1 (en) * 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
EP1694200B1 (en) * 2003-11-03 2010-09-29 MicroCHIPS, Inc. Medical device for sensing glucose
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
WO2005057175A2 (en) 2003-12-09 2005-06-23 Dexcom, Inc. Signal processing for continuous analyte sensor
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
US7286884B2 (en) 2004-01-16 2007-10-23 Medtronic, Inc. Implantable lead including sensor
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
WO2009048462A1 (en) 2007-10-09 2009-04-16 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
JP2008501037A (en) * 2004-06-01 2008-01-17 マイクロチップス・インコーポレーテッド Devices and methods for measuring and enhancing transport of drugs or analytes to / from medical implants
US20070100222A1 (en) * 2004-06-14 2007-05-03 Metronic Minimed, Inc. Analyte sensing apparatus for hospital use
US7344500B2 (en) * 2004-07-27 2008-03-18 Medtronic Minimed, Inc. Sensing system with auxiliary display
US7146939B2 (en) * 2004-09-14 2006-12-12 Federal-Mogul Worldwide, Inc. Anti-cavitation diesel cylinder liner
US7303543B1 (en) * 2004-12-03 2007-12-04 Medtronic Minimed, Inc. Medication infusion set
RU2430264C2 (en) * 2004-12-16 2011-09-27 Индепендент Нэчурэл Ресорсиз, Инк. Power system built around float-type pump
US7704229B2 (en) 2005-02-03 2010-04-27 Medtronic Minimed, Inc. Insertion device
US20060184104A1 (en) * 2005-02-15 2006-08-17 Medtronic Minimed, Inc. Needle guard
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060272652A1 (en) * 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US20070033074A1 (en) * 2005-06-03 2007-02-08 Medtronic Minimed, Inc. Therapy management system
US20070016449A1 (en) * 2005-06-29 2007-01-18 Gary Cohen Flexible glucose analysis using varying time report deltas and configurable glucose target ranges
US20070066956A1 (en) * 2005-07-27 2007-03-22 Medtronic Minimed, Inc. Systems and methods for entering temporary basal rate pattern in an infusion device
US20070060870A1 (en) * 2005-08-16 2007-03-15 Tolle Mike Charles V Controller device for an infusion pump
US20090227855A1 (en) * 2005-08-16 2009-09-10 Medtronic Minimed, Inc. Controller device for an infusion pump
US20070060869A1 (en) * 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump
US7737581B2 (en) * 2005-08-16 2010-06-15 Medtronic Minimed, Inc. Method and apparatus for predicting end of battery life
US20070093786A1 (en) * 2005-08-16 2007-04-26 Medtronic Minimed, Inc. Watch controller for a medical device
DE102005043376B4 (en) * 2005-09-12 2013-08-01 Austriamicrosystems Ag Oscillator arrangement and method for generating a periodic signal
US7713240B2 (en) 2005-09-13 2010-05-11 Medtronic Minimed, Inc. Modular external infusion device
US7725148B2 (en) * 2005-09-23 2010-05-25 Medtronic Minimed, Inc. Sensor with layered electrodes
US9072476B2 (en) 2005-09-23 2015-07-07 Medtronic Minimed, Inc. Flexible sensor apparatus
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20070173712A1 (en) * 2005-12-30 2007-07-26 Medtronic Minimed, Inc. Method of and system for stabilization of sensors
US8114269B2 (en) 2005-12-30 2012-02-14 Medtronic Minimed, Inc. System and method for determining the point of hydration and proper time to apply potential to a glucose sensor
US7774038B2 (en) 2005-12-30 2010-08-10 Medtronic Minimed, Inc. Real-time self-calibrating sensor system and method
US20070169533A1 (en) * 2005-12-30 2007-07-26 Medtronic Minimed, Inc. Methods and systems for detecting the hydration of sensors
US7985330B2 (en) * 2005-12-30 2011-07-26 Medtronic Minimed, Inc. Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy
US8114268B2 (en) * 2005-12-30 2012-02-14 Medtronic Minimed, Inc. Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US7548133B2 (en) * 2006-04-06 2009-06-16 Preco Electronics, Inc. Modulation of an RF transmit signal
US20070247254A1 (en) * 2006-04-06 2007-10-25 Preco Electronics, Inc. Modulation of an RF Transmit Signal
US20070255125A1 (en) * 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems
US8073008B2 (en) 2006-04-28 2011-12-06 Medtronic Minimed, Inc. Subnetwork synchronization and variable transmit synchronization techniques for a wireless medical device network
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
KR101611240B1 (en) 2006-10-25 2016-04-11 프로테우스 디지털 헬스, 인코포레이티드 Controlled activation ingestible identifier
US20080139910A1 (en) * 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US10154804B2 (en) * 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
KR101475666B1 (en) * 2007-02-01 2014-12-23 프로테우스 디지털 헬스, 인코포레이티드 ingestible event marker systems
CN103066226B (en) 2007-02-14 2016-09-14 普罗透斯数字保健公司 There is the in-body power source of high surface area electrode
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US20080269723A1 (en) * 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US20080300572A1 (en) * 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
WO2008154312A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US20090112626A1 (en) * 2007-10-30 2009-04-30 Cary Talbot Remote wireless monitoring, processing, and communication of patient data
WO2009070648A2 (en) 2007-11-27 2009-06-04 Medtronic, Inc. Humanized anti-amyloid beta antibodies
US8313467B2 (en) 2007-12-27 2012-11-20 Medtronic Minimed, Inc. Reservoir pressure equalization systems and methods
JP5048849B2 (en) * 2008-02-15 2012-10-17 カーディアック ペースメイカーズ, インコーポレイテッド Medical electrical lead with proximal protection
WO2009102972A1 (en) * 2008-02-15 2009-08-20 Cardiac Pacemakers, Inc. Modular, zone-specific medical electrical lead design
US20090240099A1 (en) * 2008-02-29 2009-09-24 Otologics, Llc Bi-modal cochlea stimulation
US9295786B2 (en) * 2008-05-28 2016-03-29 Medtronic Minimed, Inc. Needle protective device for subcutaneous sensors
US8334495B2 (en) * 2008-06-25 2012-12-18 Semiconductor Energy Laboratory Co., Ltd. Photometric device including a photoelectric conversion element for detecting illuminance of light
DK2313002T3 (en) 2008-07-08 2018-12-03 Proteus Digital Health Inc Data basis for edible event fields
US20100069997A1 (en) * 2008-09-16 2010-03-18 Otologics, Llc Neurostimulation apparatus
US8208973B2 (en) * 2008-11-05 2012-06-26 Medtronic Minimed, Inc. System and method for variable beacon timing with wireless devices
US8279011B2 (en) * 2008-12-17 2012-10-02 Modiotek Co., Ltd. Amplifier circuit and method of signal amplification
US20100160740A1 (en) * 2008-12-24 2010-06-24 Gary Cohen Use of Patterns in a Therapy Management System
US9330237B2 (en) * 2008-12-24 2016-05-03 Medtronic Minimed, Inc. Pattern recognition and filtering in a therapy management system
CN102341031A (en) 2009-01-06 2012-02-01 普罗秋斯生物医学公司 Ingestion-related biofeedback and personalized medical therapy method and system
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9044588B2 (en) * 2009-04-16 2015-06-02 Cochlear Limited Reference electrode apparatus and method for neurostimulation implants
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8344847B2 (en) 2009-07-09 2013-01-01 Medtronic Minimed, Inc. Coordination of control commands in a medical device system having at least one therapy delivery device and at least one wireless controller device
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
US8487758B2 (en) 2009-09-02 2013-07-16 Medtronic Minimed, Inc. Medical device having an intelligent alerting scheme, and related operating methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US8386042B2 (en) 2009-11-03 2013-02-26 Medtronic Minimed, Inc. Omnidirectional accelerometer device and medical device incorporating same
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
US8574201B2 (en) 2009-12-22 2013-11-05 Medtronic Minimed, Inc. Syringe piston with check valve seal
US8755269B2 (en) 2009-12-23 2014-06-17 Medtronic Minimed, Inc. Ranking and switching of wireless channels in a body area network of medical devices
US20110152970A1 (en) * 2009-12-23 2011-06-23 Medtronic Minimed, Inc. Location-based ranking and switching of wireless channels in a body area network of medical devices
US8396563B2 (en) 2010-01-29 2013-03-12 Medtronic, Inc. Clock synchronization in an implantable medical device system
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2011149461A1 (en) 2010-05-27 2011-12-01 Medtronic, Inc. Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
US8603033B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device and related assembly having an offset element for a piezoelectric speaker
US8562565B2 (en) 2010-10-15 2013-10-22 Medtronic Minimed, Inc. Battery shock absorber for a portable medical device
US8603032B2 (en) 2010-10-15 2013-12-10 Medtronic Minimed, Inc. Medical device with membrane keypad sealing element, and related manufacturing method
US8479595B2 (en) 2010-10-20 2013-07-09 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8474332B2 (en) 2010-10-20 2013-07-02 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8495918B2 (en) 2010-10-20 2013-07-30 Medtronic Minimed, Inc. Sensor assembly and medical device incorporating same
US8690855B2 (en) 2010-12-22 2014-04-08 Medtronic Minimed, Inc. Fluid reservoir seating procedure for a fluid infusion device
US8628510B2 (en) 2010-12-22 2014-01-14 Medtronic Minimed, Inc. Monitoring the operating health of a force sensor in a fluid infusion device
US8197444B1 (en) 2010-12-22 2012-06-12 Medtronic Minimed, Inc. Monitoring the seating status of a fluid reservoir in a fluid infusion device
US8469942B2 (en) 2010-12-22 2013-06-25 Medtronic Minimed, Inc. Occlusion detection for a fluid infusion device
US9463309B2 (en) 2011-02-22 2016-10-11 Medtronic Minimed, Inc. Sealing assembly and structure for a fluid infusion device having a needled fluid reservoir
US20120211946A1 (en) 2011-02-22 2012-08-23 Medtronic Minimed, Inc. Sealing element for a hollow needle of a fluid infusion device
US9393399B2 (en) 2011-02-22 2016-07-19 Medtronic Minimed, Inc. Sealing assembly for a fluid reservoir of a fluid infusion device
US9283318B2 (en) 2011-02-22 2016-03-15 Medtronic Minimed, Inc. Flanged sealing element and needle guide pin assembly for a fluid infusion device having a needled fluid reservoir
US8614596B2 (en) 2011-02-28 2013-12-24 Medtronic Minimed, Inc. Systems and methods for initializing a voltage bus and medical devices incorporating same
US9101305B2 (en) 2011-03-09 2015-08-11 Medtronic Minimed, Inc. Glucose sensor product and related manufacturing and packaging methods
US8564447B2 (en) 2011-03-18 2013-10-22 Medtronic Minimed, Inc. Battery life indication techniques for an electronic device
US9018893B2 (en) 2011-03-18 2015-04-28 Medtronic Minimed, Inc. Power control techniques for an electronic device
EP3575796B1 (en) 2011-04-15 2020-11-11 DexCom, Inc. Advanced analyte sensor calibration and error detection
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CA2842952C (en) 2011-07-21 2019-01-08 Proteus Digital Health, Inc. Mobile communication device, system, and method
JP6443802B2 (en) 2011-11-07 2018-12-26 アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. Analyte monitoring apparatus and method
US9610401B2 (en) 2012-01-13 2017-04-04 Medtronic Minimed, Inc. Infusion set component with modular fluid channel element
US8603026B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Dynamic pulse-width modulation motor control and medical device incorporating same
US8523803B1 (en) 2012-03-20 2013-09-03 Medtronic Minimed, Inc. Motor health monitoring and medical device incorporating same
US8603027B2 (en) 2012-03-20 2013-12-10 Medtronic Minimed, Inc. Occlusion detection using pulse-width modulation and medical device incorporating same
US20130338630A1 (en) 2012-06-07 2013-12-19 Medtronic Minimed, Inc. Diabetes therapy management system for recommending adjustments to an insulin infusion device
US9333292B2 (en) 2012-06-26 2016-05-10 Medtronic Minimed, Inc. Mechanically actuated fluid infusion device
US8808269B2 (en) 2012-08-21 2014-08-19 Medtronic Minimed, Inc. Reservoir plunger position monitoring and medical device incorporating same
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US20140066884A1 (en) 2012-08-30 2014-03-06 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9849239B2 (en) 2012-08-30 2017-12-26 Medtronic Minimed, Inc. Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9623179B2 (en) 2012-08-30 2017-04-18 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US8870818B2 (en) 2012-11-15 2014-10-28 Medtronic Minimed, Inc. Systems and methods for alignment and detection of a consumable component
US9522223B2 (en) 2013-01-18 2016-12-20 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9033924B2 (en) 2013-01-18 2015-05-19 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9107994B2 (en) 2013-01-18 2015-08-18 Medtronic Minimed, Inc. Systems for fluid reservoir retention
US9308321B2 (en) 2013-02-18 2016-04-12 Medtronic Minimed, Inc. Infusion device having gear assembly initialization
WO2014197402A1 (en) 2013-06-04 2014-12-11 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US8920381B2 (en) 2013-04-12 2014-12-30 Medtronic Minimed, Inc. Infusion set with improved bore configuration
US9433731B2 (en) 2013-07-19 2016-09-06 Medtronic Minimed, Inc. Detecting unintentional motor motion and infusion device incorporating same
US9402949B2 (en) 2013-08-13 2016-08-02 Medtronic Minimed, Inc. Detecting conditions associated with medical device operations using matched filters
TWM480212U (en) * 2013-08-16 2014-06-11 Min-Chuan Lin Integrated circuit with multi-readout voltage to frequency transformation
US9889257B2 (en) 2013-08-21 2018-02-13 Medtronic Minimed, Inc. Systems and methods for updating medical devices
US9880528B2 (en) 2013-08-21 2018-01-30 Medtronic Minimed, Inc. Medical devices and related updating methods and systems
US9259528B2 (en) 2013-08-22 2016-02-16 Medtronic Minimed, Inc. Fluid infusion device with safety coupling
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US9750878B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Closed-loop control of glucose according to a predicted blood glucose trajectory
US9750877B2 (en) 2013-12-11 2017-09-05 Medtronic Minimed, Inc. Predicted time to assess and/or control a glycemic state
US10105488B2 (en) 2013-12-12 2018-10-23 Medtronic Minimed, Inc. Predictive infusion device operations and related methods and systems
US9849240B2 (en) 2013-12-12 2017-12-26 Medtronic Minimed, Inc. Data modification for predictive operations and devices incorporating same
US9694132B2 (en) 2013-12-19 2017-07-04 Medtronic Minimed, Inc. Insertion device for insertion set
US9399096B2 (en) 2014-02-06 2016-07-26 Medtronic Minimed, Inc. Automatic closed-loop control adjustments and infusion systems incorporating same
US9861748B2 (en) 2014-02-06 2018-01-09 Medtronic Minimed, Inc. User-configurable closed-loop notifications and infusion systems incorporating same
US9610402B2 (en) 2014-03-24 2017-04-04 Medtronic Minimed, Inc. Transcutaneous conduit insertion mechanism with a living hinge for use with a fluid infusion patch pump device
US10001450B2 (en) 2014-04-18 2018-06-19 Medtronic Minimed, Inc. Nonlinear mapping technique for a physiological characteristic sensor
US10232113B2 (en) 2014-04-24 2019-03-19 Medtronic Minimed, Inc. Infusion devices and related methods and systems for regulating insulin on board
US9681828B2 (en) 2014-05-01 2017-06-20 Medtronic Minimed, Inc. Physiological characteristic sensors and methods for forming such sensors
US10275572B2 (en) 2014-05-01 2019-04-30 Medtronic Minimed, Inc. Detecting blockage of a reservoir cavity during a seating operation of a fluid infusion device
US10152049B2 (en) 2014-05-19 2018-12-11 Medtronic Minimed, Inc. Glucose sensor health monitoring and related methods and systems
US10007765B2 (en) 2014-05-19 2018-06-26 Medtronic Minimed, Inc. Adaptive signal processing for infusion devices and related methods and systems
US10274349B2 (en) 2014-05-19 2019-04-30 Medtronic Minimed, Inc. Calibration factor adjustments for infusion devices and related methods and systems
US9839753B2 (en) 2014-09-26 2017-12-12 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US9833563B2 (en) 2014-09-26 2017-12-05 Medtronic Minimed, Inc. Systems for managing reservoir chamber pressure
US10279126B2 (en) 2014-10-07 2019-05-07 Medtronic Minimed, Inc. Fluid conduit assembly with gas trapping filter in the fluid flow path
US9833564B2 (en) 2014-11-25 2017-12-05 Medtronic Minimed, Inc. Fluid conduit assembly with air venting features
US9987420B2 (en) 2014-11-26 2018-06-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US10195341B2 (en) 2014-11-26 2019-02-05 Medtronic Minimed, Inc. Systems and methods for fluid infusion device with automatic reservoir fill
US9943645B2 (en) 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
US9636453B2 (en) 2014-12-04 2017-05-02 Medtronic Minimed, Inc. Advance diagnosis of infusion device operating mode viability
US9937292B2 (en) 2014-12-09 2018-04-10 Medtronic Minimed, Inc. Systems for filling a fluid infusion device reservoir
US10307535B2 (en) 2014-12-19 2019-06-04 Medtronic Minimed, Inc. Infusion devices and related methods and systems for preemptive alerting
US10265031B2 (en) 2014-12-19 2019-04-23 Medtronic Minimed, Inc. Infusion devices and related methods and systems for automatic alert clearing
US10307528B2 (en) 2015-03-09 2019-06-04 Medtronic Minimed, Inc. Extensible infusion devices and related methods
US10449298B2 (en) 2015-03-26 2019-10-22 Medtronic Minimed, Inc. Fluid injection devices and related methods
US9999721B2 (en) 2015-05-26 2018-06-19 Medtronic Minimed, Inc. Error handling in infusion devices with distributed motor control and related operating methods
US10137243B2 (en) 2015-05-26 2018-11-27 Medtronic Minimed, Inc. Infusion devices with distributed motor control and related operating methods
US10575767B2 (en) 2015-05-29 2020-03-03 Medtronic Minimed, Inc. Method for monitoring an analyte, analyte sensor and analyte monitoring apparatus
US10010668B2 (en) 2015-06-22 2018-07-03 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and a force sensor
US9879668B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and an optical sensor
US9878095B2 (en) 2015-06-22 2018-01-30 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and multiple sensor contact elements
US9993594B2 (en) 2015-06-22 2018-06-12 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and rotor position sensors
US9987425B2 (en) 2015-06-22 2018-06-05 Medtronic Minimed, Inc. Occlusion detection techniques for a fluid infusion device having a rotary pump mechanism and sensor contact elements
US10478557B2 (en) 2015-08-21 2019-11-19 Medtronic Minimed, Inc. Personalized parameter modeling methods and related devices and systems
US10293108B2 (en) 2015-08-21 2019-05-21 Medtronic Minimed, Inc. Infusion devices and related patient ratio adjustment methods
US10201657B2 (en) 2015-08-21 2019-02-12 Medtronic Minimed, Inc. Methods for providing sensor site rotation feedback and related infusion devices and systems
US20170053552A1 (en) 2015-08-21 2017-02-23 Medtronic Minimed, Inc. Management and prioritization of the delivery of glycemic insight messages
US10463297B2 (en) 2015-08-21 2019-11-05 Medtronic Minimed, Inc. Personalized event detection methods and related devices and systems
JP6213538B2 (en) * 2015-09-24 2017-10-18 横河電機株式会社 Signal processing circuit
US10117992B2 (en) 2015-09-29 2018-11-06 Medtronic Minimed, Inc. Infusion devices and related rescue detection methods
US11501867B2 (en) 2015-10-19 2022-11-15 Medtronic Minimed, Inc. Medical devices and related event pattern presentation methods
US11666702B2 (en) 2015-10-19 2023-06-06 Medtronic Minimed, Inc. Medical devices and related event pattern treatment recommendation methods
US10146911B2 (en) 2015-10-23 2018-12-04 Medtronic Minimed, Inc. Medical devices and related methods and systems for data transfer
US10037722B2 (en) 2015-11-03 2018-07-31 Medtronic Minimed, Inc. Detecting breakage in a display element
US10449306B2 (en) 2015-11-25 2019-10-22 Medtronics Minimed, Inc. Systems for fluid delivery with wicking membrane
US10589038B2 (en) 2016-04-27 2020-03-17 Medtronic Minimed, Inc. Set connector systems for venting a fluid reservoir
MX2019000888A (en) 2016-07-22 2019-06-03 Proteus Digital Health Inc Electromagnetic sensing and detection of ingestible event markers.
US10340957B2 (en) 2016-10-28 2019-07-02 Avago Technologies International Sales Pte. Limited Methods and devices for monitoring optical signals
US11097051B2 (en) 2016-11-04 2021-08-24 Medtronic Minimed, Inc. Methods and apparatus for detecting and reacting to insufficient hypoglycemia response
US10238030B2 (en) 2016-12-06 2019-03-26 Medtronic Minimed, Inc. Wireless medical device with a complementary split ring resonator arrangement for suppression of electromagnetic interference
KR20180072313A (en) * 2016-12-21 2018-06-29 에스케이하이닉스 주식회사 Capacitance sensing circuits
US10272201B2 (en) 2016-12-22 2019-04-30 Medtronic Minimed, Inc. Insertion site monitoring methods and related infusion devices and systems
US10532165B2 (en) 2017-01-30 2020-01-14 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10500135B2 (en) 2017-01-30 2019-12-10 Medtronic Minimed, Inc. Fluid reservoir and systems for filling a fluid reservoir of a fluid infusion device
US10363365B2 (en) 2017-02-07 2019-07-30 Medtronic Minimed, Inc. Infusion devices and related consumable calibration methods
US10552580B2 (en) 2017-02-07 2020-02-04 Medtronic Minimed, Inc. Infusion system consumables and related calibration methods
US11207463B2 (en) 2017-02-21 2021-12-28 Medtronic Minimed, Inc. Apparatuses, systems, and methods for identifying an infusate in a reservoir of an infusion device
US10646649B2 (en) 2017-02-21 2020-05-12 Medtronic Minimed, Inc. Infusion devices and fluid identification apparatuses and methods
CN111246797A (en) 2017-10-24 2020-06-05 德克斯康公司 Pre-attached analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
JP2019138758A (en) 2018-02-09 2019-08-22 ルネサスエレクトロニクス株式会社 Semiconductor circuit for impedance measurement
CN110572157B (en) * 2019-08-30 2021-04-27 中勍科技有限公司 Temperature compensation method for I/F conversion circuit board
CN111638744B (en) * 2020-04-30 2022-05-24 北京航天时代光电科技有限公司 Current frequency conversion circuit
CN112843473B (en) * 2020-12-30 2023-08-04 创领心律管理医疗器械(上海)有限公司 Cardiac pacing system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757770A (en) * 1971-02-22 1973-09-11 Bio Tel Western Physiological pressure sensing and telemetry means employing a diode connected transistor transducer
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
EP0232451A1 (en) * 1986-02-10 1987-08-19 LGZ LANDIS & GYR ZUG AG Method and device for the conversion of an electrical signal into a proportional frequency
US4942401A (en) * 1989-02-24 1990-07-17 John Fluke Mfg. Co., Inc. Analog to digital conversion with charge balanced voltage to frequency converter having polarity responsive offset
EP0670499A1 (en) * 1994-03-04 1995-09-06 Kabushiki Kaisha Toshiba Voltage to frequency converter
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5750926A (en) 1995-08-16 1998-05-12 Alfred E. Mann Foundation For Scientific Research Hermetically sealed electrical feedthrough for use with implantable electronic devices

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3757770A (en) * 1971-02-22 1973-09-11 Bio Tel Western Physiological pressure sensing and telemetry means employing a diode connected transistor transducer
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
EP0232451A1 (en) * 1986-02-10 1987-08-19 LGZ LANDIS & GYR ZUG AG Method and device for the conversion of an electrical signal into a proportional frequency
US4942401A (en) * 1989-02-24 1990-07-17 John Fluke Mfg. Co., Inc. Analog to digital conversion with charge balanced voltage to frequency converter having polarity responsive offset
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
EP0670499A1 (en) * 1994-03-04 1995-09-06 Kabushiki Kaisha Toshiba Voltage to frequency converter
US5750926A (en) 1995-08-16 1998-05-12 Alfred E. Mann Foundation For Scientific Research Hermetically sealed electrical feedthrough for use with implantable electronic devices

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
JP2002513602A (en) * 1998-04-30 2002-05-14 セラセンス、インク. Analyte monitoring system and method of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11020026B2 (en) 2002-05-22 2021-06-01 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US9549693B2 (en) 2002-05-22 2017-01-24 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US10052051B2 (en) 2002-05-22 2018-08-21 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10376143B2 (en) 2003-07-25 2019-08-13 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US9986942B2 (en) 2004-07-13 2018-06-05 Dexcom, Inc. Analyte sensor
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
EP1968693A4 (en) * 2005-12-22 2011-04-27 Proteus Biomedical Inc Implantable integrated circuit
EP1968693A2 (en) * 2005-12-22 2008-09-17 Proteus Biomedical, Inc. Implantable integrated circuit
US11596332B2 (en) 2006-01-17 2023-03-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11191458B2 (en) 2006-01-17 2021-12-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US10265000B2 (en) 2006-01-17 2019-04-23 Dexcom, Inc. Low oxygen in vivo analyte sensor
US10791928B2 (en) 2007-05-18 2020-10-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US9907497B2 (en) 2009-07-02 2018-03-06 Dexcom, Inc. Analyte sensor
US11559229B2 (en) 2009-07-02 2023-01-24 Dexcom, Inc. Analyte sensor
US10420494B2 (en) 2009-07-02 2019-09-24 Dexcom, Inc. Analyte sensor
US9320466B2 (en) 2009-07-02 2016-04-26 Dexcom, Inc. Analyte sensor

Also Published As

Publication number Publication date
US5917346A (en) 1999-06-29
CA2303022C (en) 2006-01-24
DE69819533T2 (en) 2004-09-30
JP3958933B2 (en) 2007-08-15
DE69819533D1 (en) 2003-12-11
AU9314698A (en) 1999-03-29
CA2303022A1 (en) 1999-03-18
EP1012974B1 (en) 2003-11-05
JP2001516980A (en) 2001-10-02
EP1012974A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
US5917346A (en) Low power current to frequency converter circuit for use in implantable sensors
US5999849A (en) Low power rectifier circuit for implantable medical device
US5999848A (en) Daisy chainable sensors and stimulators for implantation in living tissue
US5769873A (en) Meter for measuring battery charge delivered in an implantable device
EP0183534B1 (en) Skeletal tissue stimulator and a low voltage oscillator circuit for use therein
US6171252B1 (en) Pressure sensor with increased sensitivity for use with an implantable medical device
EP2198521B1 (en) Chopper-stabilized analog-to-digital converter
EP2291005B1 (en) Multichannel cochlea implant having neural telemetry reaction
US5674264A (en) Feedback system to control electrode voltages in a cochlear stimulator and the like
US4414979A (en) Monitorable bone growth stimulator
US7221977B1 (en) Method and apparatus for measuring battery depletion in implantable medical devices
US20030036772A1 (en) Method and system for medical lead impedance test
JP2002518963A (en) Multi-channel implantable cochlear stimulator
WO2010056438A2 (en) Shielded stimulation and sensing system and method
Yiğit et al. A pulse-width modulated cochlear implant interface electronics with 513 µW power consumption
Najafi et al. A multichannel monolithic wireless microstimulator
RU2172060C2 (en) Constant voltage amplifier
Talukder et al. High resolution implantable microsystem and probe design for retinal prosthesis
CN116208186A (en) Fully differential receiver for receiving a conducted communication signal
CA1180392A (en) Monitorable bone growth stimulator

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2303022

Country of ref document: CA

Ref country code: CA

Ref document number: 2303022

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 511247

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998946040

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998946040

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1998946040

Country of ref document: EP